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Purpose: The primary aim of the study (i.e. Chapter 3) was to compare the magnitude of 
retinal vascular reactivity in arterioles of varying diameter in healthy, young subjects. The 
secondary aims were to determine: a) if there are any order effects in terms of provoking 
vasoconstriction or vasodilation first; and b) the repeatability of the vascular reactivity 
measurements. An additional aim (i.e. Chapter 4) was to determine the effect of healthy 
aging on the relationship between retinal vascular reactivity and vessel diameter. Method: 
The sample comprised 10 healthy, young subjects (mean age 26.5 years, SD 4.04) and 7 
healthy, older subjects (mean age 55.43 years, SD 5.41). Each subject from the young age 
group attended for three sessions. The first session was used to determine eligibility and 
select hemodynamic measurement sites. At sessions 2 and 3, O2 and CO2 were sequentially 
administered to the subjects using a face mask and sequential re-breathing circuit (to 
maintain standardized hyperoxia and hypercapnia). The order of vasoconstriction and 
vasodilation was varied across sessions 2 and 3. The design of the protocol was simplified 
for the subjects from the older age group. Each subject from the older group attended for one 
visit. O2 and CO2 were administered to the subjects using a face mask and sequential re-
breathing circuit. The order of gas provocation was varied among the subjects (i.e. 
hyperoxia or hypercapnia first). For both groups, measurements of vessel diameter, 
centerline blood velocity and derived blood flow were acquired at each condition (i.e. 
baseline, during stabilized vasoconstriction, vasodilation, and recovery) at two discrete 
measurement sites along the supero-temporal arteriole. Results: The results of the repeated 
measures ANOVA showed a significant difference between the narrow and wide 
measurement sites for the younger group for flow (p≤ 0.0003) and a significant influence of 
 
 v
inspired gas provocation on flow for both protocols (p<0.0001). In addition, the interaction 
of measurement site and inspired gas provocation was significant (p<0.0001). The 
magnitude of retinal vascular reactivity showed a significantly greater blood flow response 
for the wide measurement site (p<0.0001). O2 provocation resulted in vasoconstriction that 
was still present up to 10 minutes after cessation of the stimulus (order effect of O2; 
p≤0.046). No such order effect was apparent for CO2 provocation (order effect of CO2; 
p=0.352). The group mean blood flow Coefficient of Repeatability (COR) for the narrow 
measurement site was 0.74 µl/min (relative to group mean flow of 4.85 µl/min ± SD 1.31) 
and for the wide measurement site was 1.49 µl/min (relative to group mean flow of 11.29 
µl/min ± SD 3.55). There was no difference between the young and the older age groups in 
retinal vascular reactivity for both the narrow (two-tailed Student t-test, p=0.8692) and wide 
(two-tailed Student t-test, p=0.2795) measurement sites. Conclusion: This study 
demonstrated that the magnitude of retinal vascular reactivity was greater for arteriolar 
measurement sites with wider baseline vessel diameters. In addition, it demonstrated that 
hyperoxic provocation resulted in a persistent vasoconstriction up to 10 minutes after 
cessation of the stimulus. The study demonstrated that the repeatability of retinal blood flow 
measurements in absolute terms is lower for smaller diameter vessels. Finally, this study 
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1 Introduction 
The retina is able to regulate blood flow in response to different metabolic demands. There 
are several animal and human studies demonstrating a change in retinal vessel diameters1-3 
as well as in retinal 4 and optic nerve head blood flow 5-7 as a result of provocation with 
diffuse luminance flicker, O2, CO2, etc. Like in the brain, blood flow in retinal vessels is 
strongly coupled to neural activity, which has been recently established using laser Doppler 
flowmetry 5 and retinal vessel diameter measurements 1;2;8.  
 
Hemodynamics is the study of the properties and mechanisms that control the flow of blood. 
Blood flow within an organ or vascular network is driven by the difference between the 
arterial and venous pressures across the organ which is termed perfusion pressure (i.e. 
pressure gradient). The vascular smooth muscle cells have an intrinsic ability to either 
constrict or dilate in response to increase or decrease of the perfusion pressure, respectively. 
The smooth muscles respond by contracting when the lumen of a blood vessel is suddenly 
expanded, as occurs when intravascular pressure is suddenly increased.  Conversely, a 
reduction in intravascular pressure results in vasodilation. Therefore the arterioles respond to 
intravascular pressure as a stimulus 9. 
 
Vascular reactivity is the magnitude of change of hemodyamic factors to a provocative 
stimulus (e.g. an increase in partial pressure of oxygen or carbon dioxide in the blood). 
There are several studies demonstrating constriction to oxygen and dilation to carbon 
dioxide 10;11. Hyperoxia, increased partial pressure of oxygen (PaO2) in systemic arterial 
blood, is known to be a potent vasoconstrictor stimulus. Conversely, hypercapnia, increased 
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partial pressure of carbon dioxide (PaCO2) in systemic arterial blood, is known to be a 
potent vasodilatory stimulus.  
 
1.1 Anatomy and Physiology of Retinal Vessels 
The microcirculation of the retina is composed of arterioles, capillaries and venules. Arteries 
transport the blood to the tissues under a high pressure; therefore, the arteries have strong 
vessel walls. Arterioles are small resistance vessels (20-150 µm) composed of an 
endothelium surrounded by one or more layers of smooth muscle cells. The function of the 
arterioles is to regulate how much blood is delivered to the downstream capillary bed. The 
diameter of the arterioles depends on the contractile state primarily of the smooth muscle, 
which is regulated by multiple factors, such as endothelium derived constricting factors 
(EDCF), endothelium derived relaxing factors (EDRF), and circulating vasoactive 
hormones. Capillaries (6-10 µm diameter) are composed of highly attenuated (very thin) 
endothelial cells surrounded by basement membrane and manifest an absence of smooth 
muscle. Capillaries represent the site of exchange for fluids, nutrients, electrolytes, 
hormones, and other substances between the blood and the interstitial fluid. Hence, the walls 
of the capillaries have several very small pores permeable to water and other small 
molecules, as well as being very thin. Capillaries are classified as continuous, fenestrated, or 
discontinuous. Continuous capillaries are present in the retina. Continuous capillaries are the 
most impermeable type and result in the formation of the blood retinal barrier, similar to that 
of the brain-blood barrier. The venules collect the blood from the capillaries. These venules 
become progressively thicker in diameter and become veins. The blood pressure in the veins 
is very low, therefore, their vessel walls are very thin so the surrounding skeletal muscle can 
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either constrict to aid transport of the blood back to the heart or dilate so that the veins act as 
a reservoir for the blood; this mechanism permits modulation of the volume of blood in the 
circulation. The cross-sectional area of the veins is therefore four times larger than arteries, 
to enable the storage of blood 12. 
 
Physically, the first barrier between blood and tissue in the retinal circulation are endothelial 
cells which prevent plasma from leaking out of the vessel. They are also important in the 
autoregulation of the blood flow, which will be described later. The endothelium consists of 
a monolayer of cells covering the inner wall of the vasculature. The vascular endothelium is 
strategically located between the circulating blood and the vascular smooth muscle cells 13. 
The second vascular layer is the smooth muscle which can constrict and dilate. The smooth 
muscle cells are enclosed by an internal and an external elastic lamina. The internal elastic 
lamina is located between the smooth muscle cells and the endothelium and transmits 
signals between the two layers. The outer layer protects the vessel and attaches the vessel 
loosely to the surrounding tissues 14. 
 
In summary, retinal arterioles are composed of endothelial cells and smooth muscle. By 
contrast, retinal capillaries are made up of tight, non-fenestrated endothelial cells surrounded 
by a basement membrane containing pericytes and mural cells. The endothelial cells are 
joined together by zonula occludens, thereby preventing leakage from arterioles, capillaries 





1.1.1 The Vascular Systems of the Human Retina 
The human eye obtains its blood mainly from the ophthalmic artery (OA), which is the first 
branch of the internal carotid artery and the only branch of the internal carotid outside the 
cranium 16. The adult neural retina is supported by two distinct vascular systems, the inner 
retinal vessels and the choroidal vessels. The two beds vary in both their embryonic 
differentiation pattern and functionally in the adult organism. The retinal vasculature has 
barrier properties similar to those observed in the brain, whereas the choroidal vessels 
demonstrate a greatly fenestrated phenotype 17. 
 
A. The retinal blood vessels. 
The retinal blood vessels nourish the inner layers of the retina. The inner retina maintains its 
blood via the aortic artery, common carotid arteries, internal artery, ophthalmic artery and 
finally central retinal artery (CRA). The CRA enters the optic nerve 10-15 mm behind the 
globe and runs forward in the central section of the nerve along the central retinal vein. CRA 
supplies the inner two third of the retina, the most anterior portion of the superficial nerve 
fiber layer of the optic nerve head and to some extent the retrolaminar optic nerve.  
 
B. The choroidal vessels. 
The outer retinal layers, including the photoreceptors, are nourished by the choroid. The 
uveal system, specifically the choriocapillaries supply the deeper outer layers, including 
photoreceptors and bipolar cells. The short posterior ciliary arteries directly supply the 
choroid and the long posterior ciliary arteries travel in the suprachoroidal space anteriorly 
then supply the choroid anteriorly via recurrent branches. 
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In summary, retinal tissue is nourished by two vascular systems of blood vessels that differ 
anatomically and physiologically: the inner retina is nourished by the distribution of the 
central retinal artery. The outer retina is nourished by the underlying choriocapillaries via 
the short and long posterior ciliary arteries. Blood is drained by the retinal venules into the 
central retinal vein and finally the ophthalmic vein. 
 
1.1.2 Venous Outflow 
Retinal venous drainage takes place via the central retinal vein, which leaves the eye through 
the optic nerve and parallels the CRA. The central retinal vein pours into the superior 
ophthalmic vein or, rarely, directly into the cavernous sinus.  
 
1.2 Blood Flow 
The human cardiac cycle comprises of a systolic (i.e. contraction) and diastolic (i.e. 
relaxation) components. The time in which the ventricle contracts and the blood is driven 
out into the aorta is called systole. Systole generates a dicrotic wave which is secondary to 
valve closure that generates a brief pressure rise. The intervening dip is called the dicrotic 
notch. The ventricle receives blood while relaxed during diastole. Arterial pressure is 
pulsatile because the heart pumps blood intermittently 18;18. 
 
The rate of blood flow defines the amount of blood that passes a point in the vascular system 
at a given point in time. Normally the blood flow is expressed in microlitres per minute 
(µl/min). To determine the flow of the blood through a vessel it is important to know two 
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factors. First, the difference of the blood pressure (∆P) at the two ends of the vessel and 
second the resistance (R) that originates from the inner frictional forces, also termed shear 
stress 19. Based on Ohm’s Law (sometimes referred as Darcy’s Law):  
 
R
PQ ∆=                     (1.1) 
 
The blood flow (Q) is proportional to the perfusion pressure difference between two points 
(P1 – P2) and inversely proportional to the resistance (R) 19. This equation demonstrates that 
there are only two ways to increase the flow, either increase the perfusion pressure 
(difference between arterial and venous pressure) or decrease the vascular resistance. 
Changes in vascular resistance result from the contraction and relaxation of the narrow, 
terminal branches of the arterial system (i.e. resistance arterioles) 14. 
 
Resistance to flow is dependent on the properties of the fluid and the lumen through which 
the fluid is flowing. Using steady blood flow conditions through a cylindrical tube, 
resistance is proportional to the viscosity (η) and length (L) and inversely proportional to the 
fourth power of the radius (r) of the vessel. 
 
4/8 rLR πη=                                (1.2) 
 
The velocity of the blood is greater in the center of the vessel because the friction created by 
the vessel wall is higher. According to Poiseuille’s law the rate of the blood flow (Q) in the 
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=                    (1.3) 
 
where ∆P is the difference of the blood pressure between to ends of the vessel, r is the radius 
of the vessel, and η is the viscosity of the blood 19. Due to the r4 effect, small changes in 
vascular tone greatly influence blood flow, and if widespread, also impact total peripheral 




1.2.1 Resistance to Blood Flow 
The impediment to blood flow in a vessel is resistance, but there is not any direct means to 
measure the resistance. Resistance to blood flow within a vascular network depends upon 
the size factors of individual vessels (i.e. length and diameter), the way they are organized in 
the vascular network (i.e. series and parallel arrangements), physical characteristics of the 
blood (i.e. viscosity, laminar flow versus turbulent flow) and extravascular mechanical 
forces acting upon the vasculature (in terms of the eye, the intraocular pressure) 19.  
 
1.2.2 “Conductance” of Blood Flow in a Vessel and its Relation to Resistance  
The rate of the blood flow through a vessel for a particular pressure difference is termed the 
conductance. Conductance is the reciprocal of resistance: 
 
Resistance
1eConductanc =                              (1.4) 
 
When the blood flow is turbulent, minor changes in the diameter of a vessel causes 
substantial changes in the vessel’s ability to conduct blood. The conductance of the vessel 
increases in proportion to the fourth power of the diameter, in accordance with the following 
formula: 19 
Conductance∝Diameter4     
4r
LR η∝                       (1.5) 
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Where R is vessel resistance, L is length, η is viscosity of the blood, and r4 is the fourth 
power of radius. 
 
1.2.3 Laminar Blood Flow 
The normal condition for blood flow throughout most of the circulatory system is defined as 
laminar flow.  It is differentiated by concentric layers of blood moving at different velocities 
in parallel down the length of a blood vessel. Basically, laminar flow is when a fluid flows 
in parallel layers, with no disruption between the layers. The highest velocity (Vmax) is 
located in the center of the vessel and the lowest velocity (V=0) is seen along the vessel 
wall19. 
 
1.2.4 Poiseuille’s Law    
Poiseuille’s law is a physical law that states the velocity of a liquid flowing through a 
capillary is directly proportional to the pressure of the liquid and the fourth power of the 
radius of the capillary and is inversely proportional to the viscosity of the liquid and the 
length of the capillary. 
 
Cross sections of a large and a small vessel are shown in the Figure 1.1. The concentric rings 
inside the vessel point out that there are different velocities in each ring and the central ring 
displays the highest velocity because of laminar flow. That is, the blood in the ring 
contacting the wall in the vessel hardly flows because of its adherence to vascular 
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endothelium. The next ring of blood toward the center of the vessel is in contact with the 
first ring and, therefore flows more rapidly. The third, fourth and fifth ring similarly flow at 
successively greater velocities. Thus the blood that is next to the wall of vessel flows 
extremely slowly, where as that in the middle of the vessel flows extremely fast. In a small 
vessel, all the blood is near the wall so that a rapidly flowing central stream of blood simply 
does not exist.  
 
Figure 1. 1 Cross section of large and small vessel 
 
The following formula can be derived, known as Poiseuille’s law, by integrating the 









=                       (1.6) 
 
In which Q stands for the rate of blood flow, P∆ is the pressure difference between the ends 
of the vessel, r is the radius of the vessel, l is length of the vessel, and η  is viscosity of the 
blood. Note that the rate of blood flow is directly proportional to the fourth power of the 
Larger vessel Smaller vessel 
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radius of the vessel and therefore the radius plays by far the greatest role of all factors in 
determining the rate of blood flow through a vessel 19. 
 
1.2.5 Blood Flow in the Normal Human Retina 
The determination of parameters that reflect local blood flow in the eye can be acquired by 
measurement of perfusion pressure, resistance, vessel diameter and vascular blood velocity. 
Blood flow in the human retina is relatively constant but can be influenced by factors such 
as moderate variations in perfusion pressure (i.e. mean arterial pressure - intraocular 
pressure). The perfusion pressure can be varied by either changes in blood pressure or 
intraocular pressure. Unlike in the choroid, where CNS controlled sympathetic nerves 
control blood flow, inner retinal blood flow is autoregulated by changes in the vascular 
resistance depending on the contractile state of the retinal arterioles. The relationship 
between flow rate and vessel diameter applies to arterioles and venules, although the blood 
flow rate in temporal retinal vessels is much greater than in nasal vessels. For a fixed vessel 
diameter, the blood flow rate as well as the blood speed in a retinal arteriole is greater than 
in the retinal venule 19. The retinal volumetric blood flow rate can be determined 20;21,25  
using the formula 
SVQ mean ×=                       (1.7) 
Where S is the cross-sectional area of the measurement site which is equal to 4/2Dπ  and  
2




1.3 Ocular Perfusion Pressure (OPP) 
The perfusion pressure is the pressure within the vasculature. The ocular perfusion pressure 
can be defined as the local arterial blood pressure minus the intraocular pressure 22. A 
reduction in OPP can be achieved by either a reduction in arterial blood pressure or an 
increase in IOP 12. The OPP can be calculated with the equation: 
 
              (1.9) 
where BPmean is the mean arterial blood pressure and IOP is the intraocular pressure 23.  
 
1.4 Vascular Tone Regulation 
The degree that a blood vessel constricts relative to the maximally dilated state is defined as 
vascular tone. Vascular tone is a protection mechanism to guard against transient increases 
in perfusion pressure. Vascular tone is maintained by a balance between the endothelial 
vasodilators (e.g., nitric oxide) and vasoconstrictors (e.g., endothelin-1) so that, for example, 
reduced formation of vasodilators would result in vasoconstriction. A number of regulatory 
systems and factors, such as circulating hormones, as well as metabolic, myogenic and 
neurogenic factors, participate in the overall regulation of vascular tone 24,25.  
 
IOPBPOPP mean −= 32
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1.5 Autoregulation and Metabolic Autoregulation  
Autoregulation is the major regulatory mechanism of retinal blood flow, such that a change 
in the arterial blood pressure induces a compensatory change in diameter so that the blood 
flow is kept constant. In other words, change in perfusion pressure results in the 
manifestation of local blood flow regulation, termed as autoregulation. Autoregulation is 
defined as “the ability of a vascular bed to maintain blood flow to the tissues under 
conditions of varying perfusion pressure” 26.  
 
Metabolic autoregulation is defined as the ability to increase perfusion in response to altered 
tissue needs 27. For example, when metabolic activity increases blood flow will 
proportionally increase. Autoregulation and metabolic autoregulation represent distinct 




1.6 Endothelial Regulation of the Retinal Vasculature 
Retinal circulation displays an effective autoregulation. Local mediators released by 
endothelial cells and surrounding retinal tissue play an important role in the regulation of 
retinal circulation. The endothelium can be activated by different stimuli, such as oxygen 
and carbon dioxide transported by the circulating blood, to release potent relaxing (nitric 
oxide, etc.) or contracting factors (endothelin, etc.). These endothelium-derived vasoactive 
factors act upon the smooth muscle cells that surround the endothelial cells (and to a lesser 
extent the pericytes that surround the capillaries) to regulate blood flow locally. In many 
vascular diseases, such as hypercholesterolemia, athero-/arterio-sclerosis, hypertension, 
diabetes, vasospastic syndrome, ischemia and reperfusion, the function of the endothelium 
can be disrupted. The secretion of vasoactive substances by the vascular endothelium can be 
manipulated by therapeutic agents. The vascular endothelium plays a critical role in the 
modulation of blood flow in both physiological and patho-physiological situations. The 
manipulation of this regulatory system by therapeutic agents might help with new 
approaches to treat vascular disorders 13. Such therapeutic agents might include β-adrenergic 
blockers, angiotensin-converting-enzyme (ACE) inhibitors, various platelet inhibitors, such 









1.6.1.1 Nitric Oxide 
The endothelium controls vasodilation by releasing endothelium-derived relaxing factors 
(EDRF), principally nitric oxide (NO). NO, with a very short half-life, is a strong 
endothelium-derived vasodilator 28-33. NO is synthesized by three distinct isoforms of nitric 
oxide synthase (NOS). Endogenous NO is derived from the metabolism of L-arginine by the 
catalyzing action of nitric oxide synthase. The activity of eNOS is controlled by 
concentration of intracellular calcium 34. 
 
Recent studies strongly support the role of NO in the modulation of retinal blood flow in 
humans. NO synthase inhibition significantly reduces retinal arteriole and venule diameter, 
which indicates that basal NO secretion contributes to retinal vascular tone 1. In addition, 
NO plays an important role in flicker-induced vasodilatation of the human retinal 
vasculature 1. Nitric oxide also plays a role in hypercapnia-induced vasodilatation in the 
choroid and is a modulator of pressure autoregulation in this vascular bed  35;36. However, 
the underlying mechanism of hypercapnia-induced vasodilatation has yet to be clearly 
defined. The release of NO in both vascular smooth muscle cells and pericytes triggers the 
release of cyclic guanosine monophosphate leading to dephosphorylation of myosin light 





1.6.1.2 Other Vasodilators  
There are other vasodilators that are produced from endothelium such as prostacyclins 
(PGI2, ecoprostenol). Prostacyclin induces vasodilation and inhibits the aggregation of 




Endothelins are the most potent vasoconstrictors. Endothelin is a large peptide (21-amino-
acid) 37;38. The circulating endothelin levels are low indicating that it primarily acts as a local 
vascular regulatory factor; the peptide is cleared from the circulation by the lungs, the 
kidneys, and the liver 39-41. Endothelins consist of endothelin-1, -2 and -3, which act through 
the endothelin receptors A and B. Endothelin receptor A is located on the vascular smooth 
muscle and B on the vascular endothelial cell wall. One of the ways that endothelin receptor 
A mediates vasoconstriction is by the amplified influx of calcium ions. In the general 
circulation, the endothelial cells discharge vasoactive substances both spontaneously and 
after chemical stimulation e.g., circulating hormones, or physical stimulation e.g. shear 
stress. The retinal vasculature demonstrates pronounced vasoconstriction in response to 
hyperoxia, which appears to be related to the constant oxygen demand of the retina 42. 
Endothelin-1 is the main EDCF involved in hyperoxia-induced vasoconstriction in the 




1.6.2.2 Norepinephrine and Epinephrine  
Norepinephrine is an especially strong vasoconstrictor hormone; however, epinephrine is 
less potent and, in some vessels, even causes mild vasodilation 19. Norepinephrine is 
released from the adrenal glands as a hormone into the blood, but it is also a 
neurotransmitter in the nervous system where it is released from noradrenergic neurons 
during synaptic transmission. As a stress hormone, it affects parts of the human brain where 
attention and impulsivity are controlled. Along with epinephrine, this compound affects the 
fight-or-flight response, activating the sympathetic nervous system to directly increase heart 
rate, release energy from fat, and increase muscle readiness. Epinephrine is also a hormone 
and a neurotransmitter which is secreted from the adrenal medula. Epinephrine is a 
catecholamine, a sympathomimetic monoamine derived from the amino acids phenylalanine 
and tyrosine 25. 
 
1.6.2.3 Angiotensin  
Small arterioles are effectively constricted by the effect of angiotensin. If constriction 
happens in an isolated tissue area, the blood flow to that area can be rigorously deprived. 
The primary precursor is renin, made by the kidneys, and elevated when blood volume is 
low; the next substance needed for this reaction is a liver protein, angiotensinogen. When 
both rennin and angiotensinogen are present in the blood, local factors can then form this 




Vasopressin is a more powerful vasoconstrictor than angiotensin. Vasopressin is a 
antidiuretic hormone. It is secreted from nerve endings projecting into the posterior pituitary 
gland and also by nerve endings in the hypothalamus 19;25.  
 
1.6.2.5 Cyclooxygenase Products  
The endothelial cyclooxygenase pathway produces many contracting factors, including 
thromboxane A2, prostaglandin H2 or superoxide anions. These factors are chiefly produced 




1.7 Regulation in Retinal Vasculature 
The retinal microcirculation is specialized to distribute oxygen and nutrients to areas of 
metabolic need. Retinal arterioles do not have an autonomic nerve supply but they are 
thought to be intrinsically able to constrict or dilate, that is autoregulate, in order to keep 
local perfusion constant or adapted to the local metabolic needs. Thus, within certain limits, 
vascular perfusion remains independent of the local perfusion pressure. It is believed that the 
retina is effectively autoregulated and that blood flow regulation is mainly brought about via 
metabolic and myogenic influences on smooth muscle cells in the arteriolar wall. Pericytes 
also participate in retinal blood flow regulation at the capillary level. Pericyte regulatory 
responsibility in capillaries has been demonstrated in vivo. Pericytes may adjust lumen size 
by contracting and relaxing and thereby control capillary perfusion 48. 
 
1.7.1 Metabolic, Myogenic and Neurogenic “Autoregulation” of Blood Flow 
The myogenic theory of autoregulation suggests that increase in blood pressure (perfusion 
pressure) and hence transmural (i.e. across the vessel wall) pressure results in contraction of 
the smooth muscle cell. Conversely, a reduction in intravascular pressure results in smooth 
muscle relaxation and vasodilation. Endothelial derived vasoactive agents are thought to be 
responsible for initiating the myogenic contraction 49-51 in response to increase in perfusion 
pressure. The myogenic response is inhibited by calcium-channel inhibitors 49.   
 
The metabolic theory states that vascular resistance is adjusted so that blood flow maintains 
the concentration of certain metabolites within narrow limits. In other words, local arteriolar 
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smooth muscle tone is regulated by the local concentration of metabolic products, such as 
the partial pressure of oxygen and carbon dioxide (pO2 and pCO2) in the arterial blood 
supply. This response occurs independently of perfusion pressure and is sometimes referred 
to as metabolic autoregulation or vascular reactivity.  
 
It has been accepted that myogenic and metabolic autoregulation are involved in the 
regulation of ocular blood flow 9. 
 
In 1999 Orgul and co-workers discussed the probable mechanisms underlying 
autoregulation 25: 
 
1. Metabolic hypothesis: According to this theory, local arteriolar smooth muscle 
tone is regulated by the local concentration of metabolic products, such as the 
partial pressure of oxygen and carbon dioxide (pO2 and pCO2) in the arterial 
blood supply. This response occurs independently of perfusion pressure and it 
sometimes referred to as metabolic autoregulation or vascular reactivity.   
 
2. Myogenic hypothesis: In general, as local blood pressure and, hence the 
transmural tension, are increased, arterioles respond actively with constriction. 
Endothelial derived vasoactive agents are thought to be responsible for initiating 
the myogenic contraction 49-51 in response to change in perfusion pressure. The 




3. Neurogenic autoregulation: Studies have found that there is no vasoactive 
autonomic nerve supply to the retina. Sympathetic nerves innervate the central 
retinal artery up to the lamina cribosa, but not further, and therefore do not have 
effect on the retinal blood flow.  
 
1.7.2 Shear Stress  
Rapid flow of blood through a vascular segment causes a viscous drag at the luminal surface 
of endothelial cells, which can be expressed as shear stress 19. This stress contorts the 
endothelial cells in the direction of flow (i.e. re-modeling) and also results in greatly 
increased release of nitric oxide. In other words, shear stress is the pulling force applied by 
the blood against the inner vascular endothelial wall.  The magnitude of shear stress depends 
on the shear rate (rate of blood flow) and the blood viscosity. The magnitude of shear stress 
modulates diameter adaptive responses which are aimed to keep the shear stress value 
constant. An increase in shear stress will result in vasoconstriction thereby reducing blood 
flow and reducing shear stress. Changes in endothelial wall morphology occur if shear stress 




1.8 Retinal Vascular Response to O2 and CO2 
It has been demonstrated in several studies that retinal blood flow depends on arterial 
oxygen tension 53;53-55. Administrating oxygen has been used as a stimulus to induce retinal 
vascular reactivity. Vascular reactivity is the change of hemodynamic parameters in 
response to a given provocation. It has been shown in both animal 56-58 and human 54;55;59;60 
experiments that hyperoxia induces a pronounced decrease in retinal blood flow. To 
maintain retinal tissue oxygen concentration relatively constant, retinal blood flow varies 
inversely with the partial pressure of arteriolar oxygen (pO2). Principally, vascular reactivity 
is regulated via NO and endothelin-1. The mechanism of hyperoxia is ET-dependent 43. 
Hyperoxia has been shown to stimulate ET-1 release from retinal vascular endothelial cells 
in animal 58 and in human 43. Oxygen promotes local vasoconstriction of the arterioles, 
venules, and capillaries in the retina whereas carbon dioxide results in vasodilatation 10. 
Conversely, hypercapnia induces an increase in retinal blood flow and this mechanism is 
thought to be primarily nitric oxide dependent. In the retinal circulation, NO regulates basal 




1.9 Relationship between Vessel Diameter and Vascular Reactivity 
Kiss and co-workers (2002) showed an inverse relationship between the magnitude of 
vascular reactivity and vessel diameter. That is, smaller diameter vessels constricted to a 
greater degree than larger vessels in response to hyperoxia 42. Nagel and co-workers (2003) 
didn’t find any correlation between retinal vascular reactivity and vessel diameter in 
response to retinal flicker 61. Similarly, Polak and co-workers (2002) noticed no difference 
in the flicker response of the peripapillary retinal arterioles 3. More recently, Knudtson and 
co-workers (2004) noticed a greater magnitude of vessel wall pulsatility as a result of the 
pulse cycle in smaller compared to larger retinal arterioles 62. Clearly, the relationship 
between vessel diameter and the magnitude of vascular reactivity remains ambiguous. 
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1.10 Influence of Age on Retinal Blood Flow and Vascular Reactivity 
Various organs in the human body are influenced by aging. Although it has been suggested 
that retinal blood flow and autoregulation decreases in healthy people above 40 years of age 
63, the age-related change of these two distinct parameters in elderly healthy subjects is still 
equivocal. Boehm and co-workers (2005) found that there is a correlation between age and 
optic nerve head blood flow; the perfusion of the optic nerve head decreased with increasing 
age 64. Furthermore, Groh and co-workers (1996) noticed a significant decrease of blood 
flow of the retina with increasing age and also reported a decrease in blood velocity in the 
central retinal artery 65. Conversely, Harris and co-workers (2000) suggested that aging does 
not affect the central retinal arterial flow velocity; however, they suggested that ophthalmic 
arterial end-diastolic velocity is age-dependent 66. They also reported that the flow velocities 
in the posterior ciliary arteries in men were independent of age; however, the end-diastolic 
velocity of the posterior ciliary arteries was found to decrease with age in women. Grunwald 
(1998) reported no significant correlation between choroidal blood velocity and the subjects 
age 67. There is also limited evidence to suggest that age may have an impact on the 
autoregulatory response of the retinal arterioles 68. Blum and co-workers (2000) found that 




1.11 Techniques for Measuring Ocular Blood Flow in Humans 
The eye allows the noninvasive study of vascular hemodynamics in the human body. There 
are various factors that may influence the control and regulation of ocular blood flow, such 
as metabolic demands, blood nutrients, and metabolic by-products, perfusion pressure, and 
blood gasses. The numerous interactions among these factors are complex, and therefore 
they must be studied to understand the physiology of hemodynamics and possible 
hemodynamic alterations in disease. 
 
There are a number of techniques for measuring ocular blood flow. Only one commercially 
available technique can provide volumetric blood flow measurements in absolute units, and 
it is restricted to the measurement of flow in large retinal vessel. At this time, volumetric 
flow measurements in absolute units from retinal capillaries and from the choroid are not 
possible. However, a number of hemodynamic measurement techniques that measure 
parameters that reflect blood flow in the retina are available. Each of these techniques is 
discussed in detail below. 
 
1.11.1 Angiographic Techniques 
Novotny and Alvis originally introduced fluorescein angiography 39. Clinically, this method 
has become an important tool in the investigation of blood-retinal barrier leakage but can 
also be used to extract qualitative blood flow information from the angiograms. 
Considerable efforts have been made to quantify aspects of retinal blood flow using 
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angiographic techniques, whereby the measurement of the time required for the dye to pass 
through the retinal circulation is determined.  
 
Relative concentrations of fluorescein in retinal vessels are calculated for each consecutive 
angiographic picture. Dye dilution curves can then be derived for arterioles and venuls of the 
retina. The mean circulation time of the retina, defined as the difference between venous and 
arterial times, has a negative relationship with retinal blood velocity. Retinal blood flow can 
be derived if retinal vessel diameter is simultaneously measured. This technique has been 
modified employing video-angiography 40;41;69 and scanning laser ophthalmoscopy 70-71;72. 
As an alternative to mean retinal circulation time, retinal hemodynamics can be assessed by 
arterio-venous passage time. Arterio-venous passage time is the time between the first 
appearance of the dye in a retinal artery and in the corresponding vein 41. 
 
1.11.2 Blue Field Entoptic Technique  
The method is based on the subjective assessment of the blue field entoptic phenomenon 
73;74. By illuminating the retina with blue light, the density and velocity of leucocytes 
flowing in the macular capillaries can be determined. The blue field phenomenon can be 
seen by looking into a homogenous blue field and fixating upon a central target. The blue 
light needs to be a narrow optical spectrum with a wavelength of around 430nm. Only the 
red blood cells (RBCs) absorb short-wavelength light where as the white blood cells 
(WBCs) will reflect the light. The subject will perceive WBCs moving under the blue light 
in a 10° to 15° radius central area relative to the fovea 42;73,75. By comparing the subject’s 
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perceived WBCs velocity to reference velocities, the Vmean and the pulsatility of motion can 
be subjectively determined. The parameters provide information about the retinal blood flow 
and the flow pulsatility. The major disadvantages of this technique are that the 
reproducibility is often poor which is due to the technique being subjective and the results 
are influenced by patient fatigue. Furthermore, people with low visual acuity are  unable to 
see their own leucocytes in the blue light 73. 
 
1.11.3 Color Doppler Imaging (CDI) 
CDI obtains valuable diagnostic information by projecting sound into the body and 
observing how it is reflected and scattered. The CDI probe sends out sound waves and 
utilizes the time taken for echoes to return to map structure and movement. Ultrasound 
imaging devices can apply this information to quantify the exact location of the sources of 
reflection within the body 16. Furthermore, CDI measures the frequency of reflected sound 
waves to determine the velocity of blood flow within the ophthalmic artery, long posterior 
ciliary arteries, short posterior ciliary arteries and central retinal artery. By adding color to 
the B-scan output, the velocity of the blood can be more readily visualized. Particles moving 
towards the probe are pictured red-to-white and particles moving away from the probe are 
pictured blue-to-white. Using the Doppler equation, the shift of frequency can be calculated 
76. Color Doppler imaging enables the measurement of blood flow velocity in the CRA, 
CRV and PCA. The measurements can be implemented without a clear view and is therefore 
applicable for patients with poor ocular media. However, the technique requires an 
experienced operator to acquire meaningful results. Also, the pressure of the probe on the 
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eye can increase the IOP and provide inaccurate velocities. With this device it is not possible 
to measure the vessel diameter and therefore, the blood flow can not be calculated 13;77. 
 
1.11.4 Laser Speckle Technique 
The laser speckle  technique can be used for investigating aspects of retinal blood flow 
73;78;79. The laser speckle phenomenon occurs when coherent light (i.e. laser light) is 
scattered by a diffusing surface. The waves interfere and induce a pattern due to constructive 
and destructive interference. The laser speckle device consists of a fundus camera and a 
diode laser with a wavelength of 808 nm. An extra halogen lamp illuminates the area of 
interest on the fundus 79. The magnitude of blood flow through the vessel is indicated by the 
changes of spackle pattern 16. The speckle patterns are used to derive hemodynamic 
parameters. Photographs taken in laser light show different contrast between areas where 
flow occurs and areas without flow. While areas without flow have high contrast, the areas 
with flow are blurry and therefore have a lower contrast 80. Statistics are used to quantify the 
changes in hemodynamics, like the standard deviation of the intensity distribution in the 
speckle pattern. For perfect coherent light and an ideal diffuser, the standard deviation is 
equal to the mean intensity. The ratio of mean intensities (Imean) to the difference of the Imean 
and the intensity for each measurement is the normalized blur rate (NB), which quantifies 
the blood velocity 16;78. The patterns can have 50 different colors, where red distinguishes a 
fast blood velocity 16;79. It has been shown that this technique is reproducible 16;79. The 
disadvantages of this technique are that is not an absolute measurement and therefore it is 
not possible to measure the blood flow 81. 
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1.11.5 Pulsatile Ocular Blood Flow Techniques 
Blood enters the ocular blood vessels during systole and continues to flow more slowly 
during diastole and this causes a change in eye pressure proportional to the ocular volume. 
Pulsatile ocular blood flow (POBF) can be determined by pneumotonometry. The technique 
is based on the fact that blood volume increases during the systole and decreases with the 
diastolic pulse. Using POBF, a formula can be applied to calculate the ocular blood flow 
from the pulse amplitude 16;82. As a result, the technique provides immediate data but 
doesn’t measure blood flow directly.  
 
Alternatively, POBF can be assessed by measuring the distance changes between the cornea 
and the retina during the cardiac cycle using an interferometric method 82. The measurement 
point on the retina is illuminated with a coherent laser beam. The light that is reflected from 
the cornea acts as a reference wave. The fundus pulsation amplitude (FPA) is the maximum 
amplitude between the fundus and cornea during the cardiac cycle. Once again, the 
limitation of this technique is that it measures the pulsatile amplitude of blood flow rather 




1.11.6 Laser Doppler Technique 
The Doppler effect is a change in the observed frequency of a wave, such as sound or light, 
occurring when the source and or observer are in motion. This technique is applied in 
various disciplines, such as acoustics, microwave physics, optics, and astronomy. Measuring 
the blood velocity in retinal vessels of human subjects is definitely one of the most elegant 
and challenging application of the Doppler effect.  
 
1.11.6.1 Laser Doppler Velocimetry (LDV)  
Laser Doppler velocimetry measures the shift of frequency of laser light when reflected 
from moving particles. Laser light gets scattered by a stable target (e.g. vessel wall) and 
moving particles (e.g. red blood cells (RBCs)) in the vessel (Figure 1.2) 83. The light 
scattered from the moving particles is shifted in frequency, while the scatter from stable 
tissues is unaffected.  
 





f’ = f + ∆f 




The diffuse light in the vessel spreads the spectrum of scattered light and this is considered 
the Doppler Shift Power Spectrum (DSPS) 53. The backscattered DSPS contains the shifted 
(f’) and the non shifted (f) light. The difference between the frequencies (∆f) is:   
 
 λ
ν2'=−=∆ fff                            (1.10) 
 
Where υ is the velocity and λ is the wavelength in the medium. It is not considered in this 
equation that the incident beam and the reflected light can come from any direction. 




υβα )cos(cos +=∆f        (1.11) 
 
where α is the angle between the vector Vmax and the reflection and β is the angle between 
the incident beam and surface of the target (Figure 1.3)84;85. 
 
Figure 1. 3 Principle of the laser Doppler velocimetry (Vmax =maximal velocity, f=non-shifted light, f’= shifted 













The maximal velocity can be determined by the maximum Doppler frequency shift, fmax, and 







fV         (1.12) 
 
where λ is the wavelength of the incident laser in a vacuum and n the refractive index of the 
flowing medium 86. 
 
1.11.6.2 Bidirectional Laser Doppler velocimetry (BLDV) 
The absolute quantification of centerline blood velocity is possible by using two photo-
detectors 87;88. BLDV enables the measurement of the maximum blood cell velocity in larger 
retinal vessels 89. To determine the Vmax, it is important to consider that the incident beam 
should be perpendicular to the vessel so that the angle β (between incident beam and the 
vessel surface) can be set to zero (Cos β=1) 90. This angle is critical to obtain accurate 
values. To prevent incorrect measurements due to angular dependence, the back scattered 
light is measured from two different directions using two photodetectors 84. Those two 
directions are characterized by wave vectors K1 and K2 (Figure 1.4). The shift of frequency 
can be determined by the difference between the wave vectors. The two directions get 





υαα )( 12max1max2 −=−=∆ fff                     (1.13)
   
Where f1 is the frequency shift from the first wave vector and f2 is the shift from the second 
wave vector. The angles α1 and α2 are the associated angles to the frequencies f1max and f2max, 
respectively 84. Two separate photodetectors with a known angle of separation record the 
reading. This allows the absolute quantification of center-line blood velocity independent of 
the angle between the moving particle and reflected beam 91. The velocity can be determined 





fV          (1.14) 
 
Where ∆α is the angle between K1 and K2 and β is the angle between the vector Vmax and 
incident beam.  
 
Figure 1. 4 Bidirectional laser Doppler velocimetry (∆α = the angle between K1 and K2, ß = the angle between 
the incident beam and the surface, K1 and K2 = wave vectors, f1max and f2max = frequencies)  
 














A vessel exhibits Poiseuille flow and shows different velocities in the vessel 92. The 




2Π=          (1.15) 
 
Where D is the vessel diameter and Vmean is the ratio of Vmax to the constant of 
proportionality of 1.6 between the velocity in the center and the mean velocity. Poiseuille 
found that the velocity in the center of the vessel is higher than the velocity next to the 
vessel wall. 
 
1.11.6.3 Laser Doppler Flowmeter (LDF) 
The laser Doppler flowmeter (LDF) consists of a modified fundus camera and a computer 
with special software to analyze the measurements 16. A single vessel is illuminated by a 
laser beam. The bidirectional laser Doppler technique is used to determine the maximum 
center velocity. Using this technique, it is possible to determine localized volumetric flow 
measurements from capillary beds within the fundus 16. The difference between the 
maximum Doppler shift for each of the two directions determines Vmax in real units 93.  The 
LDF is similar to LDV, but LDF has a device to perform the additional signal analysis 
which is required to calculate blood flow as opposed to simply measuring velocity. It 




1.11.6.4 Scanning Laser Doppler Flowmeter 
The Scanning Laser Doppler Flowmeter (SLDF) is a non-invasive device that quickly scans 
the fundus. Each scan contains 256 individual points and the Doppler shift is calculated for 
each point separately 81. The SLDF provides a two-dimensional map of the capillary bed and 
it can be used to quantify the capillary blood flow. For each pixel in the image, the intensity 
of back scattered laser light of the retina is measured. The Heidelberg Retina Flowmeter 
utilizes this technique to derive parameters of blood flow, volume, and velocity 36.  There is 
a frequency shift shown by the moving red blood cells while light reflected from the 
surrounded tissue is unchanged. SLDF measures the intensity of back-scattered laser light 
from the retina as a function of time (to produce an intensity–time curve) for each pixel 
within the image. The two coherent components of light interfere resulting in an oscillation, 
or “beat”, of the measured light intensity. The Doppler frequency shift demonstrates the 
frequency of the intensity oscillation. Fast Fourier transforms of the intensity–time curve 
produces a power spectrum of the Doppler shift to derive parameters of blood flow, volume 
and velocity 94 at each pixel within the image. Studies have shown that the SLDF is sensitive 
to small changes in blood flow. The SLDF measures volumetric flow only in arbitrary units, 





1.11.7 Heidelberg Retina Flowmeter (HRF) 
The HRF is a confocal version of the LDF. Its laser scans the fundus quickly and each scan 
line is divided into 256 individual points. The laser scanning system of the HRF allows the 
measurement of a 10° horizontal × 2.5° vertical (i.e. approximately 2.7 mm × 0.7 mm) field 
with a resolution of 256 pixels × 64 lines, respectively. Each line of 256 pixels is scanned 
128 times at a repetition rate of 4000 Hz. The resulting image acquisition time is 2.048 s 
34;34,81. It considers the Doppler shift from each point independently. HRF quantifies scatter 
light from each point; however, it just analyzes the scatter light from the point of 
illumination. The intensity of back-scattered laser light from the retina is measured as a 
function of time for each pixel within the image (to produce an intensity-time curve). The 
oscillation, or “beat” results from the interference of incident and reflected light. The 
frequency of intensity oscillation is proportional to the Doppler frequency shift.  
 
There are some disadvantages associated with HRF: Firstly, susceptibility to eye motion 
during measurement 95, which makes some data unusable. Secondly, there is an artifactual 
flow reading even when no cells are moving, and an artifactual increase in total number of 
cell parameters when cells are in motion 95. Also, the characteristics of the retinal 
microcirculation may result in an infringement of the Bonner and Nossal assumption for 
quantification of blood flow and hence results in unreliable measurements 95. Work from our 
lab has found that artificially induced light scatter incorrectly raises HRF values 36. In brief, 
the HRF is able to provide relative blood flow measurements and therefore should only be 
used for “comparative measurements over time at the same sites” 95.  
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1.11.8 Canon Laser Blood Flowmeter (CLBF-100) 
Non-invasive, quantitative assessment of retinal arteriolar blood flow was achieved using 
the Canon Laser Blood Flowmeter, model 100 (CLBF). The principal underlying the CLBF 
is based on the Doppler effect. The CLBF utilizes fundus camera optics that incorporate two 
lasers and two photo-detectors. A red diode measurement laser (675 nm, 80 µm × 50 µm 
oval) is used to measure velocity every 0.02 sec across a 2 second measurement window 
resulting in a velocity-time trace. Velocity readings are determined using the bi-directional 
photo-detector technique i.e. the difference in Doppler shift between the two detectors is 
calculated to determine the absolute velocity of the moving red blood cells. Two sequential 
bi-directional velocity readings (i.e., path 1 and path 2) are taken by the CLBF to ensure 
consistency and are averaged to give a single velocity reading. The CLBF also uses a green 
diode vessel tracking laser system (543 nm, 1500 µm × 150 µm rectangle) to stabilize the 
measurement site, and measure the vessel diameter 96;97. It acquires multiple diameter 
readings during the first and final 60 ms  of the 2-s velocity measurement window every 
4 ms . A vessel tracking system permits a graph of eye position to be superimposed on the 
velocity time curve to aid in artifact rejection. Flow through the vessel is calculated using 
the equation: 2max
SVF = , where S is the cross-sectional area of the vessel at the 
measurement site.  Magnification effects associated with refractive and axial components of 
ametropia are corrected to provide absolute measurements of diameter (µm), velocity 
(mm/sec) and flow (µl/min). Poiseuille flow and a circular vessel cross section are assumed 




Compared to other methods of assessing retinal blood flow, the CLBF offers a quantifiable 
and repeatable method of assessing retinal hemodynamics. The major advantage of the 
CLBF 100 is that it can be used to measure blood velocity and blood flow in actual units of 
mm/s and µl/min, respectively. This permits the comparison within an eye and between the 
eyes of a patient, e.g. in clinical examples, as well as between patients. Laser speckle 
instruments and scanning laser Doppler flowmetery instruments can only provide 
information in relative units. They are limited in use to comparative measurements over time 
at the same sites because their measurement values depend on local tissue light scattering 
properties 95;98. In additional, the waveforms of the time variation of the blood velocity 
during the cardiac cycle can be analyzed by using techniques that have long been used with 
ultrasound Doppler techniques to assess circulatory characteristics in the carotid system, in 
cerebral vessels, and in the larger extraocular vessels 98.  
 
The disadvantage of the CLBF is that measurements on vessels less than 60 µm in diameter 
are difficult to achieve. In addition measurements are limited to a specific arteriolar or 
venular site and are relevant for a specific acquisition time only. A practical limitation of the 









The retina is effectively autoregulated. Small changes in vascular tone greatly influence 
blood flow, and if widespread, also impact total peripheral resistance and mean arterial 
blood pressure. The regulation of retinal blood flow is chiefly brought about via metabolic 
and myogenic autoregulation. Circulating hormones also participate in the blood flow 
regulation. NO controls blood flow in the retinal circulation by maintaining vasodilation. In 
addition, endothelins are one of the most important factors in the regulation of tone in the 
retinal vasculature by promoting vasoconstriction 43. The relationship between the 
magnitude of retinal vascular reactivity and vessel diameter is unclear. Some studies have 
shown that smaller diameter retinal vessels respond to a greater degree than larger vessels 
42;62 while others did not find any relationship 3;61.  
 
All techniques for assessing ocular blood flow have limitations. The choice of the optimal 
technique for the assessment of ocular hemodynamics depends upon the aim of the study as 
well as the protocol design. In particular, the reproducibility and the sensitivity of each 
method have to be taken into consideration. There are numerous publications about the 
reproducibility and sensitivity values for a number of the techniques 53;53;82;99-102. The Canon 
Laser Blood Flowmeter permits non-invasive quantification of retinal blood flow in absolute 
units and represents the ideal technique to determine the relationship between the magnitude 
of retinal vascular reactivity and vessel diameter by measuring the change between all 
aspects of retinal hemodynamics in response to a standardized inspired gas challenge.  
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2 Rationale, Hypotheses and Aims  
2.1 Rationale 
The relationship between the magnitude of retinal vascular reactivity and vessel diameter is 
uncertain. Some have found that smaller diameter retinal vessels respond to a greater degree 
than larger vessels 42;62, while others have found no relationship  3;61. This information might 
be useful in the standardization of retinal arteriolar blood flow assessment and provide 
information that can be used to amplify signal-to-noise ratio (i.e. defined as the ratio of a 
given transmitted signal to the background noise, or variability, of the signal). Also, 
elucidation of the relationship between the magnitude of retinal vascular reactivity and 
vessel diameter might be helpful in understanding the physiological processes of healthy 
aging and the patho-physiological processes of diseases influencing ocular perfusion, such 
as diabetes, arterio- / arthero-sclerosis, retinal vessel occlusion and glaucoma.  
 
Furthermore, previous studies 3;42;61;62 have not systematically assessed the relationship 
between retinal vascular reactivity and vessel diameter. An additional problem with these 
studies is that they used techniques that assessed hemodynamic parameters that reflected 
vascular reactivity, rather than techniques that quantified blood flow per se. Using the 
CLBF, we had the opportunity to take this area of work further by measuring the change in 
the relationship between all aspects of hemodynamics, that is vessel diameter, centerline 
blood velocity and volumetric blood flow, in response to an inspired gas challenge. Unlike 
previous studies, vascular reactivity was quantified by calculating the change in volumetric 




In Chapter 3, the influence of hypercapnia and hyperoxia on vessel diameter was determined 
to establish the overall magnitude of vascular reactivity and the resulting change in retinal 
arteriolar diameter, velocity and blood flow was quantified, in young healthy subjects. In 
addition, we set out to determine the repeatability of the retinal vascular reactivity 
measurements and to investigate if there were any order effects in terms of provoking 
vasoconstriction or vasodilation first (since both of these factors could influence and / or 
confound signal-to-noise ratio).  
 
The hypercapnic and hyperoxic gas challenges were administered using a sequential 
rebreathing circuit 103,104. This allowed the generation of an isocapnic hyperoxic challenge 
103 and a hypercapnic challenge that resulted in physiologically insignificant disturbance of 
arterial oxygen concentration 36 . Previous work from our lab has clearly demonstrated that 
our isocapnic hyperoxic and hypercapnic gas challenges result in minimal, if any, change in 
blood pressure and heart rate 36;103;105;106. Interestingly, other research groups have had 
limited success in the attainment of isocapnic hyperoxia 103, while others have completely 
ignored any possible change of arterial oxygen concentration during hypercapnia 106.  
 
The change, if any, in the retinal vascular reactivity response in healthy aging is also 
unclear. It has been found that retinal autoregulation in response to weight lifting exercise 
decreases in healthy individuals above 40 years of age 63. However, this study only assessed 
change in vessel diameter in response to provocation rather than change in volumetric blood 
flow. In Chapter 4, the relationship between retinal vascular reactivity and vessel diameter 
was investigated in elderly healthy subjects and compared to that of the young healthy 
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subjects. The protocol used for the elderly subjects was considerably shorter than that used 
for the young subjects but was shortened taking into account information gathered about 





For Chapter 3, the hypothesis was that the magnitude of vascular reactivity (as indicated by 
the overall change in retinal blood flow between the isocapnic hyperoxic and hypercapnic 
challenges) is inversely proportional to vessel diameter.  
 
Although the relationship between retinal vascular reactivity and vessel diameter is 
equivocal, there is strong evidence to support our hypothesis from the field of cerebral blood 
flow research 107;108. There is also evidence which demonstrates that the magnitude of 
microvascular autoregulatory adjustments is inversely related to the size of the coronary 
blood vessel 109. 
 
For Chapter 4, the hypothesis was that the magnitude of retinal vascular reactivity in older 
healthy subjects is reduced relative to that of healthy young subjects resulting in an 
alteration of the relationship between baseline arteriolar diameter and vascular reactivity.  
 
To the best of our knowledge, the impact of healthy aging upon the relationship between 
retinal vascular reactivity and vessel diameter has not been addressed. There is limited 






In Chapter 3, the primary aim was to determine the magnitude of retinal vascular reactivity 
in arterioles of varying diameter in healthy, young subjects. The secondary aims of Chapter 
3 were: a) To determine if there were any order effects in terms of provoking 
vasoconstriction or vasodilation first; and b) To determine the repeatability of the retinal 
vascular reactivity measurements. 
 
In Chapter 4, the aim of this pilot study was to determine the effect of healthy aging on the 
relationship between retinal vascular reactivity and vessel diameter. 
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3 The Relationship between Retinal Vascular Reactivity and Arteriolar Diameter 
3.1 Introduction  
The comprehensive study of hemodynamics in the human retina requires the noninvasive, 
quantitative measurement of blood flow. Using state of the art techniques, it is now possible 
to simultaneously measure retinal vessel diameter and centerline blood velocity and thereby 
derive volumetric retinal blood flow in absolute units. Vascular reactivity is defined as the 
magnitude of change of hemodynamic parameters shown to provocative stimuli, such as that 
initiated by the manipulation of the partial pressure of oxygen or carbon dioxide in inspired 
gases. Hyperoxia (i.e. elevated partial pressure of O2 in systemic arterial blood, PaO2) 
induces a pronounced decrease in retinal blood flow in both retinal and cerebral vessels as a 
result of vascular constriction10;53-55;60;110-119. Conversely, hypercapnia (i.e. elevated partial 
pressure of CO2 in systemic arterial blood, PaCO2) induces an increase in retinal arteriolar 
blood flow as a result of vessel dilation 11;110;113;118-121 . In summary, oxygen promotes local 
vasoconstriction of the arterioles, venules, and capillaries in the retina whereas carbon 
dioxide results in vasodilatation 10.  
 
Although it is generally accepted in the literature that smaller diameter vessels demonstrate a 
greater magnitude of vascular reactivity 107, the relationship between retinal vascular 
reactivity and vessel diameter is uncertain. The retinal arterioles represent the resistance 
vessels of the inner retina and therefore determine the overall blood flow to the capillary 
bed. Some studies have found that smaller diameter retinal venules and arterioles respond to 
a greater degree than larger vessels 62;42 while others have found no relationship between 
vessel diameter and the magnitude of vascular reactivity 3;61. None of these studies, 
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however, have systematically assessed the relationship between retinal vascular reactivity 
and vessel diameter and have invariably used techniques that measured hemodynamic 
parameters that reflected vascular reactivity but failed to quantify blood flow change per se. 
Understanding of the relationship between retinal vascular reactivity and vessel diameter 
might be useful in the standardization of retinal blood flow assessment and provide 
information that can be used to amplify signal-to-noise ratio. Also, it will aid understanding 
of the physiological processes of healthy aging and the patho-physiological processes of 
diseases that influence retinal perfusion, such as diabetes, arterio- / arthero-sclerosis, 
vascular occlusive disease and glaucoma.  
 
The primary aim of the study was to compare the magnitude of retinal vascular reactivity in 
arterioles of varying diameter in healthy, young subjects. The secondary aims were: a) To 
determine if there were any order effects in terms of provoking vasoconstriction or 
vasodilation first; and b) To determine the repeatability of the retinal vascular reactivity 
measurements. Unlike previous studies, vascular reactivity was quantified by calculating the 
change in volumetric blood flow that occurred between standardized hyperoxic and 





3.2 Materials and Methods  
3.2.1 Sample 
The sample comprised five healthy females and five healthy males of average age 26.2 years 
(range 21 to 33; SD 3.49). The sample size calculation was determined after estimating the 
standardized effect size, i.e. SD/Mean effect, for retinal arteriolar blood flow. The change in 
arteriolar blood flow relative to baseline during hyperoxia is approximately -4 µl/min 
whereas blood flow typically increases by +3 µl/min during hypercapnia (data obtained from 
Hudson lab). A mean standard deviation for retinal blood flow would be approximately 3 
µl/min. Therefore, the standardized effect size = SD / Mean effect = 3/7 = 0.43. Using a 
two-tailed α of 0.05 and β of 0.10 (i.e. 90%), the minimum required sample size is n = 3. 
 
One eye of each subject was randomly chosen for this study. All subjects had a logMAR 
visual acuity of 0.0, or better. Exclusion criteria included any refractive error > ±6.00 
Diopters sphere and / or ±1.50 Diopters cylinder, habitual smoking, treatable respiratory 
disorders (e.g. asthma), cardiovascular disease, systemic hypertension, family history of 
glaucoma or diabetes, or a history of any ocular disease. All the participants were asked to 
abstain from caffeine and red meat for 24 hours prior to their study visits. This study 
received approval by the University of Waterloo Office of Research Ethics. Informed 
consent was obtained from each subject after explanation of the nature and possible 




3.2.2 Visits  
Each subject attended for three visits. The first visit was used to determine eligibility, to 
define the retinal measurement sites for quantitative blood flow assessment, to acquire 
baseline data and to familiarize the subjects with the blood flow measurement technique. 
The second and third visits were used to assess the magnitude of retinal vascular reactivity 
in response to hyperoxic and hypercapnic stimuli. The inspired gas stimuli were 
administered consecutively at each visit, but the order of hyperoxia and hypercapnia were 
systematically reversed across the two visits (in order to identify any residual effects of one 
gas stimulus versus the other). The order of stimuli was also systematically varied between 
volunteers. 
 
3.2.3 Quantitative Assessment of Retinal Arteriolar Blood Flow 
Non-invasive, quantitative assessment of retinal arteriolar blood flow was achieved using 
the Canon Laser Blood Flowmeter, model 100 (CLBF). The principal underlying the CLBF 
is based on the Doppler effect. The CLBF utilizes fundus camera optics that incorporate two 
lasers and two photo-detectors. A red diode measurement laser (675 nm, 80 µm × 50 µm 
oval) is used to measure velocity every 0.02 sec across a 2 second measurement window 
resulting in a velocity-time trace. Velocity readings are determined using the bi-directional 
photo-detector technique i.e. the difference in Doppler shift between the two detectors is 
calculated to determine the absolute velocity of the moving red blood cells. Two sequential 
bi-directional velocity readings (i.e., path 1 and path 2) are taken by the CLBF to ensure 
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consistency and are averaged to give a single velocity reading. A second green diode vessel 
tracking laser system (543 nm, 1500 µm × 150 µm rectangle) is used to stabilize, and 
measure the vessel diameter 96;97. Multiple diameter readings are acquired during the first 
and final 60 ms  of the 2-s velocity measurement window every 4 ms . A vessel tracking 
system provides a graph of eye position to be superimposed on the velocity-time curve to aid 
in artifact rejection. Flow through the vessel is calculated using the equation: 2max
SVF = , 
where S is the cross-sectional area of the vessel at the measurement site 92;105;123.  
Magnification effects associated with refractive and axial components of ametropia are 
corrected to provide absolute measurements of diameter (µm), velocity (mm/sec) and flow 
(µl/min). Poiseuille flow and a circular vessel cross section are assumed in the calculation of 
blood flow. 
 
3.2.4 Gas Provocation 
A face mask and sequential re-breathing circuit was used to manipulate inspired and expired 
gases 103. The sequential re-breathing system comprised fresh gas and re-breathed gas 
reservoirs that were interconnected by two one-way valves and a single peep valve (Figure 
3.1). The sequential re-breathing system is assembled by adding a gas reservoir to the 
expiratory port of a commercial 3-valve oxygen delivery system (Hi-Ox80, Viasys 
Healthcare, Yorba Linda, CA) (Figure 3.1). Flow from the gas tanks was controlled using 
standard rotometers as flowmeters. Gases were mixed in a baffled container prior to being 
administered to the subject. Tidal gas concentrations, including inspired and expired O2 and 
 
 51
CO2 levels, were continuously sampled from the face mask using a rapid response critical 
care gas analyzer (Cardiocap 5; Datex-Ohmeda, Louisville, CO). Any periods of transitional 
(i.e. non-stable) gas parameters were excluded from the gas provocation analysis and also 
from the analysis of CLBF outcome measures (since hemodynamic parameters would be 
anticipated to be similarly unstable during these transition periods) 103. A proven advantage 
of the sequential re-breathing system is that it permits the manipulation of inspired O2 while 
maintaining a constant expired CO2 i.e. isocapnic hyperoxia can be readily achieved 103. 
Similarly, any change of expired O2 during manipulation of inspired CO2 is physiologically 
insignificant, although isoxic hypercapnia cannot be attained using a manually controlled 
sequential re-breathing system 106.  
 
 
Figure 3. 1 Schematic of sequential re-breathing circuit 103 Baseline: An initial air breathing period (@ a rate 
of 6 to 8 litres per minute, LPM) was employed to allow stabilization of baseline breathing parameters. 
Hypercapnia: The rate of flow of bottled air was reduced (@ a rate of 5 to 6 LPM) so that the subject partially 
breathed gas from the re-breathed bag. Isocapnic Hyperoxia: Subjects breathed O2 at a flow rate set equal to 
the subjects’ minute ventilation (determined while breathing air).  
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The gas provocation protocol was designed to reveal any order effects that might occur as a 
result of hyperoxic and hypercapnic gas challenge, to determine the repeatability of the 
vascular reactivity measurements and to determine the relationship between arteriolar 
diameter and the overall magnitude of retinal vascular reactivity. Volunteers underwent 
assessment over two separate visits in which hyperoxia (Figure 3.2) or hypercapnia (Figure 
3.3) were initiated after a baseline period of 10 minutes. The initiation of hyperoxia or 
hypercapnia after baseline was reversed for each individual across the two visits in order to 
identify any order effects of one gas challenge versus the other, and was systematically 
varied between individuals i.e. 5 subjects underwent hyperoxic challenge after baseline at 
visit 2 and 5 underwent hypercapnic challenge. A minimum of three minutes was allowed 
following initiation of each gas stimulus and recovery period prior to retinal blood flow 
assessment.  
 
After the initial gas challenge, a recovery period of 10 minutes was included prior to 
initiating a challenge which resulted in the opposite physiological vascular response to that 
of the initial challenge. During each recovery period, subjects breathed air to return their 
end-tidal O2 and CO2 to baseline values. Recovery periods were included between all 
hyperoxic and hypercapnic challenges and at the end of the protocol. Comparison of the 
various recovery periods across the protocol permitted the assessment of repeatability of the 
vascular reactivity measurements, irrespective of any identified order effects (Figures 3.2 
and 3.3). Comparison of the arteriolar responses to hyperoxia and hypercapnia, or vice 
versa, permitted the assessment of the overall magnitude of retinal vascular reactivity 
(Figures 3.2 and 3.3). The gas provocation protocol was designed to permit the assessment 
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of the overall magnitude of vascular reactivity irrespective of any order effects associated 
with one or the other of the gas challenges. For example, if the hyperoxic gas challenge 
resulted in a residual effect, while hypercapnia did not, it would be appropriate to assess 
vascular reactivity as the difference in response to CO2 and subsequently O2, respectively, 
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                       Order Effect; 1a or 1b 
                       Repeatability; 2a or 2b  
 
 
Figure 3. 2 Hyperoxia repeat gas provocation protocol utilized at visit 2 or 3 (O2; isocapnic hyperoxia. CO2; 
hypercapnia). One narrow and one relatively wide diameter measurement site along the superior temporal 
arteriole were selected for each individual. A minimum of 3 minutes was allowed following initiation of each 
condition prior to CLBF acquisition. O2 and CO2 order were systematically varied between volunteers and 
across visits. 
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                       Order Effect; 1a or 1b 
                       Repeatability; 2a or 2b 
                       Vascular Reactivity; 3a or 3b 
 
Figure 3. 3 Hypercapnia repeat gas provocation protocol utilized at visit 3 or 2. (O2; isocapnic hyperoxia. CO2; 
hypercapnia). One narrow and one relatively wide diameter measurement site along the superior temporal 
arteriole were selected for each individual. A minimum of 3 minutes was allowed following initiation of each 













The pupil of the study eye was dilated using Tropicamide 1 % (Alcon, Mississauga, Canada) 
at the beginning of each visit to achieve an adequate view of the fundus for the retinal blood 
flow image acquisition. Subjects rested for 10 minutes prior to start of each study visit to 
stabilize baseline cardiovascular and respiratory parameters. At visit 1, two separate 
measurement locations, representing different diameter values along the superior temporal 
arteriole were sought for each subject. Relatively straight segments, distant from vessel 
branches, of the superior temporal arteriole were selected. Arterioles were used in this study 
because they are primarily responsible for determining vascular resistance and because they 
obey Poiseuille flow to a greater extent than venules. Five retinal blood flow measurements 
were acquired at each location for each condition and the order of measurement location was 
randomized between subjects with respect to distance from the optic nerve head.  
 
At visits 2 and 3, subjects breathed air at a rate equivalent to their minute ventilation, 
thereby ensuring a stable FETCO2 (fractional percent end-tidal CO2 i.e. the maximum 
concentration of CO2 during each expiration), for the first 10 minutes to establish a baseline.  
At least five retinal blood flow measurements at the two distinct predetermined arteriolar 
measurement sites were acquired for each gas stimulus and recovery period following an 
initial 3 minute period of stabilization. For the hypercapnic gas challenge, the rate of flow of 
bottled air was reduced (typically to a rate of 5 to 6 Liters per minute, LPM) so that the 
subject breathed a proportion of gas from the re-breathed bag for 10 minutes. The stimulus 
was designed to result in approximately a 10% increase of FETCO2 relative to baseline. For 
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the hyperoxic gas challenge, subjects breathed O2 at a flow rate equal to their minute 
ventilation (determined while breathing air at baseline) for 10 minutes. The stimulus was 
designed to result in approximately a fractional (percent) inspired O2 (FiO2) of 95%. If 
hyperoxic provocation was undertaken following hypercapnia, retinal blood flow 
measurements were only acquired when end-tidal CO2 values had returned to baseline 
levels. At the completion of the protocol, subjects were returned to bottled air for 10 minutes 
and retinal blood flow measurements were acquired when end-tidal CO2 values had returned 
to baseline levels.  
 
3.2.6 CLBF Velocity Waveform Analysis 
CLBF analysis software was used to analyze each acquired velocity waveform. A 
standardized protocol was used to remove aberrant portions of each waveform i.e. due to eye 
movement or improper vessel tracking. For each acquisition, the maximum number of 
acceptable cycles was included in the analysis, while a minimum of one complete systolic-





3.2.7 Statistical Analysis  
Mean hemodynamic parameters were calculated for each condition (i.e. baseline, O2, CO2, 
recovery, etc.) of each individual as a function of gas provocation protocol (Figure 3.2 & 
3.3). Data points which represented “outliers”, that is any data point that fell outside the 25th 
to 75th  percentile, were retained in the analysis since the sample size was relatively small 
and, as a result, likely to generate outliers.  
 
A repeated measures analysis of variance (ANOVA) was undertaken on the group arteriolar 
diameter, blood velocity and flow to determine the significance of any change over the 
course of each protocol. Arteriolar measurement site (i.e. narrow or wide) was the within-
subject factor.  In those situations that revealed a significant ANOVA result, post hoc testing 
was undertaken using Tukey’s HSD (Honestly Significant Difference) test. Tukey’s HSD 
test is “protected” from the probability of making type I experimental errors for any pairwise 
comparison. This analysis was designed, in part, to reveal any order effects in relation to the 
provocation of vasoconstriction or vasodilation (i.e. addressing one secondary aim of the 
study). The results of this analysis, if positive, would dictate which conditions were 
compared to determine the repeatability of, and the influence of vessel diameter on, retinal 
vascular reactivity.  
 
The repeatability of the vascular reactivity measurements were determined for volumetric 
blood flow using the Coefficient of Repeatability (COR=1.96*SD of the differences) for 
both the narrow and wide measurement sites. Any evidence of a systematic order effect 
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associated with the provocation of vasoconstriction or vasodilation would dictate which 
conditions were compared to validly determine the repeatability.  
 
In order to test the influence of vessel diameter on the magnitude of retinal vascular 
reactivity (i.e. primary aim of the study), the difference in vascular response in terms of 
blood flow between hypercapnic and hyperoxic provocation was calculated. A repeated 
measures ANOVA was used to determine the significance of any difference in flow 
response between the narrow and wide measurement sites (in this analysis, gas provocation 
protocol was considered to be a within-subject factor).  Any evidence of a systematic order 
effect associated with the provocation of vasoconstriction or vasodilation would dictate 
which conditions were compared to validly determine the influence of vessel diameter on 






3.3.1 Diameter  
The baseline diameter for the narrow arteriolar measurement site was 92.40 µm (SD 13.64) 
and for the wide measurement site was 116.68 µm (SD 12.68) (re-ANOVA p<0.0001). 
 
3.3.1.1 Hyperoxia Repeat Gas Provocation Protocol (see Figure 3.2) 
The results of the repeated measures ANOVA showed a significant difference between the 
narrow and wide measurement sites for diameter (p<0.0001) and a significant influence of 
inspired gas provocation on diameter (p<0.0001). In addition, the interaction of 
measurement site and inspired gas provocation was significant (p=0.0083).  
 
The first hyperoxic provocation resulted in a significant decrease in diameter relative to 
baseline (Tukey HSD, p<0.0001) and relative to recovery 1 (p<0.0001) for both the wide 
and narrow measurement sites (see Figure 3.5 & 3.6). Hypercapnia resulted in significantly 
larger diameter values for the narrow measurement site relative to recovery 1 (p<0.0001) 
and relative to recovery 2 (p=0.0037). Similarly, the wide measurement site exhibited 
significantly larger diameter values in response to hypercapnia relative to recovery 1 
(p=0.0050) but was not different relative to recovery 2 (p=0.0901). The repeat hyperoxic 
provocation resulted in a significant decrease in diameter relative to recovery 2 (p<0.0001) 




Diameter values following the first hyperoxic (i.e. at recovery 1) provocation were 
significantly less for the narrow (p=0.0070) and wide (p=0.0191) measurement sites 
compared to baseline (see Figure 3.4 and Table 3.1). Diameter values following hypercapnia 
(i.e. at recovery 2) were not significantly different from baseline (p=0.7115, p=0.2306 for 
narrow and wide measurement sites, respectively) (see Table 3.2). Diameter values 
following the second hyperoxic provocation (i.e. at recovery 3) were not different for the 
narrow measurement site (p=0.0972) compared to baseline but were significantly less for the 
wide measurement site (p=0.0415).  
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p-value p=0.0191 p=0.0415 p=0.6833 
 
Table 3. 1Group mean diameter (SD, standard deviation) values for the narrow and wide arteriolar 
measurement sites at baseline and recovery following hyperoxic provocation in both the hyperoxia and 






Figure 3. 4 Difference in arteriolar diameter (i.e. between baseline and recovery following O2 provocations for 
both the hypercapnia and hyperoxia repeat protocols) as a function of mean diameter for wide and narrow 
arteriolar measurement sites. The p-values showing the statistical significance of any change between baseline 






Figure 3. 5 Box plots illustrating group change in retinal arteriolar diameter during the hyperoxia repeat 









Figure 3. 6 Box plots illustrating group change in retinal arteriolar diameter during the hyperoxia repeat 




3.3.1.2 Hypercapnia Repeat Gas Provocation Protocol (see Figure 3.3) 
The results of the repeated measures ANOVA showed a significant difference between the 
narrow and wide measurement sites for diameter (p<0.0001) and a significant influence of 
inspired gas provocation on diameter (p<0.0001). However, the interaction of measurement 
site and inspired gas provocation was not significant (p=0.7517).  
 
The first hypercapnic provocation resulted in a significant increase in diameter relative to 
baseline (Tukey HSD, p=0.0444) and relative to recovery 1 (p=0.0324; see Figure 3.8 & 
3.9). Hyperoxia resulted in a significant reduction in diameter (p<0.0001) relative to 
recovery 1 and relative to recovery 2 (p<0.0001). The repeat hypercapnic provocation was 
not different relative to recovery 2 (p=0.0836) and relative to recovery 3 (p=0.1063).  
 
Diameter values following hyperoxia (i.e. at recovery 2) were not significantly different 
(p=0.6833) compared to baseline and similarly following hypercapnia (i.e. at recovery 1 and 
3) were not significantly different compared to baseline (p=0.8905, p=0.7731 for recovery 1 
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p-value p=0.8905 p=0.7731 p=0.2306 
 
Table 3. 2 Group mean diameter (SD, standard deviation) values for the narrow and wide arteriolar 
measurement sites at baseline and recovery following hypercapnic provocation in both the hyperoxia and 





Figure 3. 7 Difference in arteriolar diameter (i.e. between baseline and recovery following CO2 provocations 
for both the hypercapnia and hyperoxia repeat protocols) as a function of mean diameter for wide and narrow 
arteriolar measurement sites. The p-values showing the statistical significance of any change between baseline 





Figure 3. 8 Box plots illustrating group change in retinal arteriolar diameter during the hypercapnia repeat 









Figure 3. 9 Box plots illustrating group change in retinal arteriolar diameter during the hypercapnia repeat 





3.3.2.1 Hyperoxia Repeat Gas Provocation Protocol (see Figure 3.2) 
The results of the repeated measures ANOVA showed a significant difference between the 
narrow and wide measurement sites for velocity (p=0.0018) and a significant influence of 
inspired gas provocation on velocity (p<0.0001). However, the interaction of measurement 
site and inspired gas provocation was not significant (p=0.0810).  
 
The first hyperoxic provocation resulted in a significant decrease in velocity relative to 
baseline (Tukey HSD, p<0.0001) and relative to recovery 1 (p<0.0001) for both 
measurement sites (see Figure 3.11 & 3.12). Hypercapnia resulted in a significant increase 
in velocity relative to recovery 1 and recovery 2 (p≤ 0.0020). The repeat hyperoxic 
provocation resulted in a significant decrease in diameter relative to recovery 2 (p<0.0001) 
and relative to recovery 3 (p<0.0001).  
 
Velocity values following the first hyperoxic provocation (i.e. at recovery 1) were not 
different compared to baseline (p=0.4554) (see Figure 3.10 and Table 3.3). Similarly, 
velocity values following hypercapnia (i.e. at recovery 2) were not different from baseline 
(p=0.9095) (see Table 3.4). Velocity values following the repeat hyperoxic provocation (i.e. 
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p-value p=0.4554 p=0.2512 p=0.9811 
 
Table 3. 3 Group mean diameter (SD, standard deviation) values for the narrow and wide arteriolar 
measurement sites at baseline and recovery following hyperoxic provocation in both the hyperoxia and 




Figure 3. 10 Difference in arteriolar velocity (i.e. between baseline and recovery following O2 provocations for 
both the hypercapnia and hyperoxia repeat protocols) as a function of mean velocity for wide and narrow 
arteriolar measurement sites. The p-values showing the statistical significance of any change between baseline 





Figure 3. 11 Box plots illustrating group change in retinal arteriolar velocity during the hyperoxia repeat 
protocol for the wide measurement site. 
 
Figure 3. 12 Box plots illustrating group change in retinal arteriolar velocity during the hyperoxia repeat 





3.3.2.2 Hypercapnia Repeat Gas Provocation Protocol (see Figure 3.3) 
The results of the repeated measures ANOVA showed a significant difference between the 
narrow and wide measurement sites for velocity (p=0.0006) and a significant influence of 
inspired gas provocation on velocity (p<0.0001). In addition, the interaction of measurement 
site and inspired gas provocation was significant (p=0.0231).  
 
The first hypercapnic provocation resulted in a significant increase in velocity relative to 
baseline (Tukey HSD, p=0.0096 and p=0.0003) and relative to recovery 1 (p=0.0066 and 
p<0.0001) for the narrow and wide measurement sites, respectively (see Figure 3.14 & 
3.15). Hyperoxia resulted in a significant reduction in velocity relative to recovery 1 and 
relative to recovery 2 for the narrow (p=0.0020 and p<0.0001) and wide (p=0.0009 and 
p<0.0001) measurement sites, respectively. The repeat hypercapnic provocation was not 
different relative to recovery 2 (p=0.1557 and p=0.2124) and relative to recovery 3 
(p=0.3096 and p=0.0891) for the narrow and wide measurement sites, respectively.  
 
Velocity values following first hypercapnia (i.e. at recovery 1) were not different (p=0.8904 
and p=0.4501 for narrow and wide measurement sites, respectively) compared to baseline 
(see Figure3.13 and Table 3.4). Velocity values following hyperoxia (i.e. at recovery 2) were 
not different (p=0.8961 and p=0.9811 for narrow and wide measurement sites, respectively) 
compared to baseline (see Table 3.3). Velocity values following the repeat hypercapnic 
provocation (i.e. at recovery 3) were not different (p=0.5878 and p=0.6238 for the narrow 
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p-value p=0.4501 p=0.6238 p=0.9095 
 
Table 3. 4 Group mean diameter (SD, standard deviation) values for the narrow and wide arteriolar 
measurement sites at baseline and recovery following hypercapnic provocation in both the hyperoxia and 
hypercapnia repeat protocols. The p-values designate the significance of any change between baseline and 
recovery. 
 
Figure 3. 13 Difference in arteriolar velocity (i.e. between baseline and recovery following CO2 provocations 
for both the hypercapnia and hyperoxia repeat protocols) as a function of mean velocity for wide and narrow 
arteriolar measurement sites. The p-values showing the statistical significance of any change between baseline 





Figure 3. 14 Box plots illustrating group change in retinal arteriolar velocity during the hypercapnia repeat 
protocol for the wide measurement site. 
 
Figure 3. 15 Box plots illustrating group change in retinal arteriolar velocity during the hypercapnia repeat 





3.3.3.1 Hyperoxia Repeat Gas Provocation Protocol (see Figure 3.2) 
The results of the repeated measures ANOVA showed a significant difference between the 
narrow and wide measurement sites for flow (p=0.0003) and a significant influence of 
inspired gas provocation on flow (p<0.0001). In addition, the interaction of measurement 
site and inspired gas provocation was significant (p<0.0001).  
 
The first hyperoxic provocation resulted in a significant decrease in flow relative to baseline 
(Tukey HSD, p<0.0001) and relative to recovery 1 (p<0.0001) for both the narrow and wide 
measurement sites (see Figure 3.17 & 3.18). Hypercapnia resulted in a significant increase 
in flow for both the narrow (p<0.0001 and p=0.0328) and wide (p<0.0001 and p<0.0001) 
measurement sites relative to recovery 1 and recovery 2, respectively. The repeat hyperoxic 
provocation resulted in a significant decrease in flow relative to recovery 2 (p<0.0001and 
p<0.0001) and relative to recovery 3 (p=0.0002 and p<0.0001) for both the narrow and wide 
measurement sites, respectively.  
 
Flow values following the first hyperoxic provocation (i.e. at recovery 1) were significantly 
less for the narrow (p=0.0459) and wide (p=0.0008) measurement sites compared to baseline 
(see Figure 3.16 and Table 3.5). Flow values following hypercapnia (i.e. at recovery 2) were 
not different from baseline (p=0.9097 and p=0.7118) for narrow and wide measurement 
sites, respectively (see Table 3.6). Flow values following the repeat hyperoxic provocation 
(i.e. at recovery 3) were significantly less for the narrow (p=0.0120) and wide (p<0.0001) 
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p-value p=0.0008 p<0.0001 p=0.0002 
 
Table 3. 5 Group mean diameter (SD, standard deviation) values for the narrow and wide arteriolar 
measurement sites at baseline and recovery following hyperoxic provocation in both the hyperoxia and 
hypercapnia repeat protocols. The p-values designate the significance of any change between baseline and 
recovery.                                                                                                                                                                      
 
 
Figure 3. 16 Difference in arteriolar blood flow (i.e. between baseline and recovery following O2 provocations 
for both the hypercapnia and hyperoxia repeat protocols) as a function of mean flow for wide and narrow 
arteriolar measurement sites. The p-values showing the statistical significance of any change between baseline 





Figure 3. 17 Box plots illustrating group change in retinal arteriolar blood flow during the hyperoxia repeat 





Figure 3. 18 Box plots illustrating group change in retinal arteriolar blood flow during the hyperoxia repeat 




3.3.3.2 Hypercapnia Repeat Gas Provocation Protocol (see Figure 3.3) 
The results of the repeated measures ANOVA showed a significant difference between the 
narrow and wide measurement sites for flow (p<0.0001) and a significant influence of 
inspired gas provocation on flow (p<0.0001). In addition, the interaction of measurement 
site and inspired gas provocation was significant (p<0.0001).  
 
The first hypercapnic provocation resulted in a significant increase in flow relative to 
baseline (Tukey HSD, p=0.0026 and p<0.0001) and relative to recovery 1 (p=0.0050 and 
p<0.0001) for the narrow and wide measurement sites, respectively (see Figure 3.20 & 
3.21). Hyperoxia resulted in a significant reduction in flow relative to recovery 1 and 
recovery 2 for the narrow (p<0.0001 and p=0.0004, respectively) and wide (p<0.0001 and 
p<0.0001, respectively) measurement sites. The repeat hypercapnic provocation resulted in 
a significant increase in flow relative to recovery 2 (p=0.0003 and p<0.0001) and recovery 3 
(p=0.0226 and p=0.0039) for the narrow and wide measurement sites, respectively.  
 
Flow values following the first hypercapnic provocation (i.e. at recovery 1) were not 
significantly different compared to baseline (p=0.8147 and p=0.3524) for the narrow and 
wide measurement sites, respectively (see Figure 3.19 and Table 3.6). Flow values following 
hyperoxia (i.e. at recovery 2) were not different compared to baseline for the narrow 
measurement site (p=0.2101) but were significantly less for the wide measurement site 
(p=0.0002) (see Table 3.5). Flow values following the repeat hypercapnic provocation (i.e. at 
recovery 3) were not different compared to baseline (p=0.7823 and p=0.4010) for the narrow 
and wide measurement sites, respectively. 
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 Hypercapnia Repeat Hypercapnia Repeat Hyperoxia Repeat 












































p-value p=0.6524 p=0.4010 p=0.7118 
 
Table 3. 6 Group mean diameter (SD, standard deviation) values for the narrow and wide arteriolar 
measurement sites at baseline and recovery following hypercapnic provocation in both the hyperoxia and 





Figure 3. 19 Difference in arteriolar blood flow (i.e. between baseline and recovery following CO2 
provocations for both the hypercapnia and hyperoxia repeat protocols) as a function of mean flow for wide and 
narrow arteriolar measurement sites. The p-values showing the statistical significance of any change between 





Figure 3. 20 Box plots illustrating group change in retinal arteriolar blood flow during the hypercapnia repeat 











Figure 3. 21 Box plots illustrating group change in retinal arteriolar blood flow during the hypercapnia repeat 
protocol for the narrow measurement site. 
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3.3.4 Repeatability of Vascular Reactivity 
Since hyperoxia resulted in a prolonged vasoconstriction, the repeatability of retinal vascular 
reactivity was determined by calculating the COR for blood flow values between baseline 
and recovery 2 for the hyperoxia repeat protocol (i.e. Figure 3.2; 2a rather than 2b) and 
between recovery 1 and recovery 3 for the hypercapnia repeat protocol (i.e. Figure 3.3; 2b 
rather than 2a).  
 
The group mean blood flow COR for the narrow measurement site was 0.74 µl/min (relative 
to a group mean flow of 4.85 µl/min ± SD 1.31; Figure 3.22) and for the wide measurement 








              
Figure 3. 22 Difference in arteriolar blood flow as a function of mean flow for the narrow arteriolar 
measurement site. The closed circle represents data from the hyperoxia repeat protocol and the open square 
represents the hypercapnia repeat protocol. 
 
 
+ 95% Conf. limits 
-95% Conf. limits 
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Figure 3. 23 Difference in arteriolar blood flow as a function of mean flow for the wide arteriolar 
measurement site. The closed circle represents data from the hyperoxia repeat protocol and the open square 
represents the hypercapnia repeat protocol. 
 
+95% Conf. limits 
-95% Conf. limits 
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3.3.5 Influence of Vessel Diameter on the Magnitude of Retinal Vascular 
Reactivity 
Since hyperoxia resulted in a prolonged vasoconstriction, the influence of vessel diameter on 
retinal vascular reactivity was determined by calculating the difference in flow response to 
hypercapnia and subsequently hyperoxia for both protocols (i.e. Figure 3.2; 3b rather than 
3a. Figure 3.3; 3a rather than 3b).  
 
The magnitude of retinal vascular reactivity showed a significantly greater blood flow 
response for the wide measurement site (p<0.0001; Figure 3.24). The influence of protocol 
(i.e. Figure 3.2 & 3.3) was not significant (p=0.6504) and the interaction of protocol and 







Figure 3. 24 Baseline arteriolar diameters as a function of absolute magnitude of vascular reactivity (i.e. 














3.4 Gas Parameter Results 
Group mean FiO2 (± SD) and FETCO2 (± SD) values for each gas parameter condition across 
protocols 2 and 3 are shown in Tables 3.7 and 3.8, respectively.  
 


































Table 3. 7 Fractional end-tidal CO2 and fractional inspired O2 as a function of gas parameter condition for the 
hyperoxia repeat protocol. FETCO2 is the partial pressure or maximal concentration of carbon dioxide (CO2) at 
the end of an exhaled breath expressed as a percentage of CO2. FiO2 is fractional concentration of inspired O2 
expressed as percentage of O2. 
 


































Table 3. 8 Fractional end-tidal CO2 and fractional inspired O2 as a function of gas parameter condition for the 
hypercapnia repeat protocol. FETCO2 is the partial pressure or maximal concentration of carbon dioxide (CO2) 
at the end of an exhaled breath expressed as a percentage of CO2. FiO2 is fractional concentration of inspired 
O2 expressed as percentage of O2. 
 
FiO2 showed a group mean (i.e. mean of 3 provocations across protocols 2 and 3) increase 
from 19.79% to 93.10% (paired Student t-test, p<0.0001) during hyperoxic provocation. 
FETCO2 showed a group mean (i.e. mean of 3 provocations across protocols 2 and 3) 
increase of 18.6% relative to baseline (from 37.65 mmHg to 44.67 mmHg; paired Student t-
test, p<0.0001) during hypercapnic provocation. Importantly, FETCO2 did not change 




It has been generally accepted that smaller diameter vessels demonstrate a greater magnitude 
of vascular reactivity 107. The retinal arterioles in part represent the resistance vessels of the 
inner retina and therefore contribute to the control of overall blood flow to the capillary bed. 
Some studies have found that smaller diameter retinal venules and arterioles respond to a 
greater degree than larger vessels 42;62, while others have found no relationship 3;61. Unlike 
previous work 3;42;61;62, this study found that measurement sites of wider diameter arterioles 
show a greater response in terms of the absolute magnitude of change in flow. In other 
words, the magnitude of vascular reactivity, measured as the difference in flow between O2 
and CO2 provocation, was greater for arteriolar measurement sites with wider baseline 
diameters. The difference between the results of this study and previous work may be 
explained by differences in the techniques used to assess hemodynamics and to provoke 
vascular reactivity.  
 
Kiss and co-workers (2002) 42 showed an inverse relationship between the magnitude of 
vascular reactivity and vessel diameter. Their study was performed to investigate the impact 
of 100% O2 breathing on retinal hemodynamics using blue field entoptic phenomenon and 
continuous measurement of retinal vessel diameter using the Zeiss retinal vessel analyzer 42. 
However, the subjective nature of the blue field entoptic phenomenon used to estimate 
retinal hemodynamics is widely regarded to have problems pertaining to measurement 
validity. Nagel and co-workers (2003) 61 did not find any correlation between retinal 
vascular reactivity and vessel diameter in response to retinal flicker. This study was 
designed to determine the impact of age, blood pressure and vessel diameter on the retinal 
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vessels using retinal vessel analyzer 61. Similarly, Polak and co-workers (2002) 3 noticed no 
difference to flicker provocation in the hemodynamic response of the peripapillary retinal 
arterioles. This study aimed to determine the influence of flicker frequency on flicker-
induced changes of retinal vessel diameter 3. More recently, Knudtson and co-workers 
(2004) 62 noticed a greater magnitude of vessel wall pulsatility as a result of the pulse cycle 
in smaller compared to larger retinal arterioles. This study was performed to investigate the 
impact of the pulse cycle on the measurement of retinal vessel diameters in small and large 
arterioles and venules 62. In support of Kiss and co-workers (2002) 42, Lamport and co-
workers suggested that a reduced vascular reactivity response in larger diameter vessels in 
the cerebral vasculature might be related to greater stiffness of the larger vessel wall 124. In 
addition, a larger magnitude of vascular reactivity response in smaller diameter vessels 
might be explained by inherent differences in the responsiveness of the vascular smooth 
muscle 125. 
 
The design of our study was unique in that two different locations along the same arteriole 
were sought whilst other studies have used different vessels. Also, vascular reactivity was 
quantified in our study by calculating the change in volumetric blood flow that occurred 
between standardized isocapnic hyperoxia and hypercapnia inspired gas challenges; a gas 
challenge was utilized that resulted in extreme vasoconstriction and vasodilation. In support 
of the results of our study, the number of smooth muscle cells surrounding the retinal 
vascular endothelium is progressively reduced from the optic disk along the course of the 
arterioles 126. It is of interest to note that, in terms of percentage change in blood flow, the 
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response of the retinal vessels was essentially the same, irrespective of baseline diameter 
(Figure 3.25).  
 
 
Figure 3. 25 Baseline arteriolar diameters as a function of percent magnitude of vascular reactivity (i.e. 




Hyperoxic provocation resulted in a persistent vasoconstriction that was still present within 
the period of 3 to 10 minutes after cessation of the stimulus. No such persistent order effect 
was apparent for the hypercapnic provocation. This surprising result was achieved by 
comparing the data for recovery after hyperoxia with baseline and similarly for hypercapnia; 
both diameter and flow values were significantly lower following hyperoxia compared to the 
preceding baseline, irrespective of gas provocation paradigm. Interestingly, repeat 
hypercapnic provocation failed to produce an increase of diameter (p=0.1063) and velocity 
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(p≤ 0.0891) following the intermediate hyperoxic provocation and this also suggests the 
presence of a persistent vasoconstrictive order effect. The persistent vasoconstriction after 
hyperoxia may be explained by an effect of tissue oxygenation and the half-life of 
endothelin-1. It is known that NO has a half-life of approximately 5 seconds or less 127 but 
the biological half life of endothelin-1 is 1.4 to 3.6 minutes while other studies suggest a 
half-life of 35 minutes 128. In addition, the persistent vasoconstriction following pronounced 
hyperoxia (i.e. approximately 94% inspired O2) could even reflect oxidative damage effects 
at the level of the retinal vasculature 129. Unlike diameter and flow, the velocity values after 
hyperoxia did not show any difference compared to the baseline and recovery values. This 
difference in response compared to that of diameter and flow may be explained by the 
higher variability of velocity measurements. A limitation of our study is that the transition 
from one condition to the next in terms of arterial gas concentration is not square wave; 
however, the slope of the arterial gas concentration transition is expected to be equivalent 
across conditions thereby still suggesting the presence of a persistent vasoconstrictive order 
effect. Future work will utilize a computer controlled gas sequencer to provide square wave 
changes in arterial gas concentrations. 
 
The COR of retinal blood flow was greater for arteriolar measurement sites with wider 
baseline diameters than those with narrower baseline diameters; however, the ratio of group 
mean blood flow to group mean COR (6.55 versus 7.58 for narrow and wide diameter sites, 
respectively) was similar across the measurement sites. This data demonstrates that the 
repeatability of retinal blood flow measurements in absolute terms is lower for smaller 
diameter vessels but when related to the group mean flow there is little, if any, difference in 
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repeatability between smaller and larger diameter vessels. These findings need to take into 
account the range of vessel diameters that were investigated in this study i.e. group mean 
diameter 92.40 µm (SD 13.64) versus 116.68 µm (SD 12.68) diameter.  
 
In summary, this study demonstrated that the magnitude of retinal vascular reactivity was 
greater for arteriolar measurement sites with wider baseline vessel diameters. The 
percentage change in vascular reactivity, however, was equivalent between the two 
measurement sites. In addition, it demonstrated that hyperoxic provocation resulted in a 
persistent vasoconstriction up to 10 minutes after cessation of the stimulus. Finally, the 
study demonstrated that the repeatability of retinal blood flow measurements in absolute 
terms is lower for smaller diameter vessels. However, the ratio of COR to group mean flow 
was equivalent between the two measurement sites. Future work should examine the effect 
of aging on the relationship between baseline diameter and retinal vascular reactivity and the 
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4 The Influence of Healthy Aging on the Relationship between Retinal Vascular 
Reactivity and Vessel Diameter 
4.1 Introduction 
There is a growing interest in the area of retinal vascular reactivity since this functional 
outcome measure may provide a non-invasive index of ocular, and probably systemic, 
vascular health. Vascular reactivity is defined as the magnitude of change of hemodynamic 
parameters shown to provocative stimuli, such as that initiated by the manipulation of the 
partial pressure of oxygen and carbon dioxide in inspired gases. Previous studies have 
shown that both the retinal and cerebral vessels react by constricting to oxygen and by 
dilating to carbon dioxide10;11;130. Hyperoxia (i.e. elevated partial pressure of O2 in systemic 
arterial blood, PaO2) induces a pronounced decrease in retinal blood flow in both retinal and 
cerebral vessels as a result of vasoconstriction 10;11;111;112;114;115;130;131. The vasoconstriction 
of retinal vessels and the blood flow reduction has been demonstrated using a variety of 
measurement techniques10;53-55;60;110-119. Conversely, hypercapnia (i.e. elevated partial 
pressure of CO2 in systemic arterial blood, PaCO2) induces an increase in retinal blood flow 
as a result of vessel vasodilation11;110;113;118-121. In summary, oxygen promotes local 
vasoconstriction of the arterioles, venules, and capillaries in the retina, whereas carbon 
dioxide results in vasodilation 10. 
 
Various organs in the human body are influenced by the process of aging. Although it has 
been suggested that retinal blood flow and autoregulation decreases in healthy people above 
40 years of age 63, the age-related change of these two distinct parameters in elderly healthy 
subjects is still equivocal. Boehm and co-workers (2005) found that there is a correlation 
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between age and optic nerve head blood flow; the perfusion of the optic nerve head 
decreased with increasing age 64. Furthermore, Groh and co-workers (1996) noticed a 
significant decrease of blood flow of the retina with increasing age and also reported a 
decrease in blood velocity in the central retinal artery 65. Conversely, Harris and co-workers 
(2000) suggested that aging does not affect the central retinal arterial flow velocity; 
however, they suggested that ophthalmic arterial end-diastolic velocity is age-dependent 66. 
They also reported that the flow velocities in the posterior ciliary arteries in men were 
independent of age; however, the end-diastolic velocity of the posterior ciliary arteries was 
found to decrease with age in women. Grunwald (1998) reported no significant correlation 
between choroidal blood velocity and the subjects age 67. 
 
There is also limited evidence to suggest that age may have an impact on the autoregulatory 
response of the retinal arterioles 68. Blum and co-workers (2000) found that age had a 
significant negative effect on the myogenic response, assessed using isometric exercise, of 
retinal arterioles using the Retinal Vessel Analyzer. In consideration of the potential 
important role of vascular reactivity and the ambiguity of previous results when considered 
as a whole, we have undertaken a pilot study to investigate the effect of aging on the 




4.2 Material and Methods 
4.2.1 Sample 
Before commencement of the study, ethics clearance was obtained from the Office of 
Research Ethics at the University of Waterloo and University Health Network Research 
Ethics Board, Toronto. Informed consent was obtained from all participants prior to 
enrollment in the study.  The sample comprised of 4 women and 3 men of average age 
55.43 years (range 46 to 61 years; SD 5.41). The data obtained from this group of 
individuals was compared to the data of the 10 young, healthy subjects described in Chapter 
3 i.e. five females and five males of average age 26.2 years (range 21 to 33; SD 3.49). All 
subjects had a logMAR visual acuity of 0.00, or better, and no personal or immediate family 
history of glaucoma or diabetes. Subjects with any ocular or systemic disease, 
cardiovascular or respiratory disorders, obesity (i.e. Body Mass Index of 30 and above), 
habitual smoking habits and a refractive error greater than ± 6.00 diopters sphere or ± 2.00 
diopters cylinder were excluded from the study.  In addition, subjects had to manifest a 
minimum difference of 15 µm between the narrow and wide measurement sites in order to 
be included in the study.  
 
4.2.2 Visits 
Subjects attended for one visit. Eligibility for entry into the study was determined by 
acquiring baseline information (e.g. health status) and data (e.g. weight, height, waist 
circumference). A total of 11 older healthy individuals were screened for the study. Eligible 
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subjects underwent pupil dilation and CLBF measurements at two sites along the supero-
temporal arteriole. The necessary safeguards in terms of anterior segment assessment, van 
Herrick’s anterior chamber depth assessment and intra-ocular pressure measurement were 
undertaken prior to pupil dilation. Intra-ocular pressure measurement was repeated at the 
end of the visit to ensure no post-dilation increase in intra-ocular pressure. 
 
4.2.3 Quantitative Assessment of Retinal Arteriolar Blood Flow 
Non-invasive, quantitative assessment of retinal arteriolar blood flow was achieved using 
the Canon Laser Blood Flowmeter, model 100 (CLBF). Details of the CLBF are provided in 
Section 3.2.3.  
 
4.2.4 Gas Provocation  
The face mask and sequential re-breathing circuit (Hi-Ox80, Viasys Healthcare, Yorba 
Linda, CA) described in Section 3.2.4 was used to manipulate inspired and expired gases.  
 
The gas provocation protocol used in this study was designed to minimize the order effect of 
hyperoxic provocation revealed in Chapter 3. Volunteers underwent assessment in which 
either isocapnic hyperoxia (Figure 4.1) or hypercapnia (Figure 4.2) was undertaken first. 
The order of hyperoxia and hypercapnia was systematically varied between volunteers in 
order to closely resemble the methodology used in Chapter 3. Depending on the initial gas 
challenge, a 10 or 20 minute recovery period was included to permit the return of retinal 
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hemodynamics to baseline values. A minimum of three minutes was allowed following the 
initiation of hypercapnic stimulation and recovery periods prior to retinal blood flow 
assessment. However, a minimum of ten minutes was allowed following hyperoxic 
provocation prior to retinal blood flow assessment in order to reduce any persistent 
vasoconstrictive effects. To summarize, taking into account the half life of ET-1, we chose a 
recovery period of 20 minutes following hyperoxia and ensured to undertake data collection 
in only the final 10 minutes of the 20 minute period. The methods used to achieve hyperoxia 
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Figure 4. 1 Hyperoxia first gas provocation protocol (O2; isocapnic hyperoxia. CO2; hypercapnia). A narrow 




Baseline CO2 Recovery 1 O2 Recovery 2 




Figure 4. 2 Hypercapnia first gas provocation protocol (O2; isocapnic hyperoxia. CO2; hypercapnia). A narrow 










The pupil of the study eye was dilated using Tropicamide 1 % (Alcon, Mississauga, Canada) 
to achieve an adequate view of the fundus for the retinal blood flow image acquisition. 
Subjects rested for 10 minutes prior to the start of each study visit to stabilize baseline 
cardiovascular and respiratory parameters. Two CLBF measurement sites representing 
different diameter values along the superior temporal arteriole were sought for each subject. 
Relatively straight segments, distant from vessel branches, of the superior temporal arteriole 
were selected. Five retinal blood flow measurements were acquired at each location for each 
condition and the order of measurement location was randomized between subjects with 
respect to distance from the optic nerve head. 
 
Hyperoxic and hypercapnic stimuli were consecutively administered to assess the magnitude 
of retinal vascular reactivity but the order of stimuli was systematically varied between 
subjects (4 undertook the protocol described in Figure 4.1 and 3 undertook Figure 4.2 
protocol). Data was not analyzed from the first 10 minutes of the 20 minute recovery period 
following hyperoxia to minimize any persistent vasoconstriction. The measurements during 
Recovery 2 (i.e. at the end of the procedure) were acquired without the mask and with the 




4.2.6 CLBF Velocity Waveform Analysis 
CLBF analysis software was used to analyze each acquired velocity waveform. A 
standardized protocol was used to remove aberrant portions due to eye movement and 
improper vessel tracking. For each acquisition, the maximum number of acceptable pulse 
cycles was included in the analysis, while a minimum of one complete systolic-diastolic 
cycle was essential for including a given waveform. 
 
4.2.7 Statistical Analysis 
Mean hemodynamic parameters were calculated for each condition (i.e. baseline, O2, 
recovery, CO2, recovery, etc.) of each individual (Figure 4.1 & 4.2). The magnitude of 
vascular reactivity (i.e. difference in flow between CO2 and O2 provocation) was compared 
between the older and younger age groups for the narrow and wide measurement sites (using 
two-tailed Student t-test). In order to standardize the results for the effect of differing 
measurement sites between individuals, a “vascular reactivity gradient index” was derived, 
which represented the difference in vascular reactivity between wide and narrow 






The baseline diameter for the older age group for the narrow arteriolar measurement site was 
98.87 µm (SD=14.34) and for the wide measurement site was 114.39 µm (SD=10.18) 
(paired Student t-test, p=0.0033).  
 
Comparing to equivalent results of Chapter 3, the younger age group exhibited a baseline 
diameter of 92.40 µm (SD 13.64) and 116.68 µm (SD 12.68) for the narrow and wide 




4.3.2 The Effect of Age on the Relationship between Retinal Vascular Reactivity 
and Vessel Diameter  
The relationship between baseline diameter and the magnitude of retinal vascular reactivity 
for narrow and wide measurement sites as a function of group is shown in Figure 4.3. There 
was no difference between the young and the older age groups in retinal vascular reactivity 
for both the narrow (two-tailed Student t-test, p=0.8692) and wide (two-tailed Student t-test, 




Figure 4. 3 Absolute magnitude of vascular reactivity (i.e. difference in flow between CO2 and O2 
provocation) as a function of baseline arteriolar diameters for the narrow and wide arteriolar measurement sites 




4.3.3 The Effect of Age on Retinal Vascular Reactivity Gradient Index 
The relationship between age and retinal vascular reactivity gradient index is shown in 
Figure 4.4. There was no difference between the young and the older age groups in retinal 









4.4 Gas Parameters Results 
Group mean FiO2 (± SD) and FETCO2 (± SD) values for each gas parameter condition are 
shown in Tables 4.1 and 4.2. 
 





















   
Table 4. 1 Fractional end-tidal CO2 and fractional inspired O2 as a function of gas parameter condition for the 
hyperoxia first protocol for the older age group (n=4). FETCO2 is the partial pressure or maximal concentration 
of carbon dioxide (CO2) at the end of an exhaled breath expressed as a percentage of CO2. FiO2 is the 
fractional concentration of inspired O2 expressed as percentage of O2. 
 






















Table 4. 2 Fractional end-tidal CO2 and fractional inspired O2 as a function of gas parameter condition for the 
hyperoxia first protocol for the older age group (n=3). FETCO2 is the partial pressure or maximal concentration 
of carbon dioxide (CO2) at the end of an exhaled breath expressed as a percentage of CO2. FiO2 is the 
fractional concentration of inspired O2 expressed as percentage of O2. 
 
For the older age group, FiO2 showed a group mean (i.e. mean of 2 provocation across two 
protocols) increase from 20.04% to 93.83% (paired Student t-test, p<0.0001) during 
hyperoxic provocation. FETCO2 showed a group mean (i.e. mean of 2 provocations across 
two protocols) increase of 12.6% relative to baseline (from 39.22 mmHg to 44.16 mmHg; 
paired Student t-test, p<0.0001) during hypercapnic provocation. Importantly, FETCO2 did 




The results of this pilot study suggest that there is no effect of age on the magnitude of 
retinal vascular reactivity (Figure 4.3) and on the relationship between the magnitude of 
retinal vascular reactivity and vessel diameter (Figure 4.4). We might not have observed any 
influence of age on the relationship between retinal vascular reactivity and vessel diameter 
due to study limitations. These limitations could include the small sample size, the relatively 
small difference in age between the two groups (i.e. 55.4yrs for the older group and 26.2yrs 
for the young group), subject fatigue (i.e. which limited the protocol design for the older age 
group) and, finally, the gas provocations may overwhelm any vascular reactivity deficit 
associated with healthy aging. Similar provocations have been shown to be sensitive to 
effects of diabetes mellitus 132 on retinal vascular reactivity. Future work will investigate the 
effect of healthy aging on stepped increments of gas stimuli on retinal hemodynamics.  
 
It has been generally accepted that age-induced adaptations of the vasculature contribute to a 
reduction in muscle blood flow in man 133;134. Jeppesen suggested that there is an age-related 
decrease in diameter response of retinal arterioles when the blood pressure is changed 63. 
Studies performed by Boehm and co-workers 64, Grunwald and co-workers 135 and Groh and 
co-workers 65 suggested a negative correlation between retinal blood flow and age, while 
those studies performed by Harris and co-workers 66 and Grunwald and co-workers 67 
essentially suggested no relationship between retinal blood flow and age. The impact of age 




Numerous techniques have been used by other groups to assess retinal blood flow. Jeppesen 
and co-workers (2004) investigated the age-dependent change in the myogenic response of 
retinal arterioles using the Retinal Vessel Analyzer (RVA) to evaluate change in  vessel 
diameter 63. Groh and co-workers (1996) used pulsed Doppler sonography to quantify the 
influence of age on retinal and optic nerve head blood circulation 65. Boehm and co-workers 
(2005) studied the effect of age on optic nerve head blood flow using Laser Doppler 
Flowmetry 64. Harris and co-workers (2000) used color Doppler imaging to perform a study 
on the effects of aging on the retrobulbar circulation 66. Grunwald and co-workers (1993) 
examined the effect of age on retinal macular microcirculation using the blue field 
stimulation technique 135.  
 
In this study, the effect of age on retinal vascular reactivity and on the relationship between 
the magnitude of retinal vascular reactivity and vessel diameter was investigated. Unlike 
previous work 63-65;135, this study found that there was no impact of aging on retinal 
hemodynamics and vascular reactivity. The difference between the results of this study and 
previous work may be explained by the differences in the technique used to assess 
hemodynamics and to provoke vascular reactivity. The design of our study was unique in 
that vascular reactivity was quantified by calculating the change in volumetric blood flow 






In support of our study, Muller-Delp (2006) 136 has emphasized that studies which have 
investigated change in vascular function with age were mostly conducted on large conduit 
arteries rather than on resistance arteries and arterioles 137-143. An observed effect of aging in 
large conduit arteries cannot be extended to resistance arteries and arterioles. Several studies 
have demonstrated vasoconstrictor responses in the foot to be reduced 137;144 , unchanged 
137;145 or enhanced 146 with advancing age. These studies show that age-related adaptations of 
vasoconstrictor responsiveness are heterogenous, are different between conduit arteries and 
resistance arterioles 138;147-151, are different between vascular beds 136;137;147;149;152;153 and are 
different between muscles of different fiber type 147. 
 
In summary, this study demonstrated that healthy aging does not have any effect on the 





It has been generally accepted that smaller diameter vessels demonstrate a greater magnitude 
of vascular reactivity 107. Some studies have shown that smaller diameter vessels respond to 
greater degree than larger vessels 42;62, while others have shown no relationship 3;61. Unlike 
previous work 3;42;61;62, this study found that measurement sites of wider diameter arterioles 
show a greater response in terms of the absolute magnitude of change in flow. In other 
words, the magnitude of vascular reactivity, measured as the difference in flow between O2 
and CO2 provocation, was greater for arteriolar measurement sites with wider baseline 
diameters; however, when vascular reactivity is expressed in percentage change, there was 
no influence of vessel diameter on reactivity. The difference between the results of this 
study and previous work may be explained by differences in the techniques used to assess 
hemodynamics and to provoke vascular reactivity. Also, this study was the first to 
systematically investigate the influence of retinal vessel diameter on the magnitude of retinal 
vascular reactivity.  
 
The design of our study was unique in that two different locations along the same arteriole 
were sought whilst other studies have used different vessels. Also, vascular reactivity was 
quantified in our study by calculating the change in volumetric blood flow that occurred 
between standardized isocapnic hyperoxia and hypercapnia inspired gas challenges; a gas 
challenge was utilized that resulted in extreme vasoconstriction and vasodilation. In support 
of the results of our study, the number of smooth muscle cells surrounding the retinal 
vascular endothelium is progressively reduced from the optic disk along the course of the 
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arterioles 126. It is of interest to note that, in terms of percentage change in blood flow, the 
response of the retinal vessels was essentially the same, irrespective of baseline diameter. 
 
Hyperoxic provocation resulted in a persistent vasoconstriction that was still present within 
the period of 3 to 10 minutes after cessation of the stimulus. No such persistent order effect 
was apparent for the hypercapnic provocation. This surprising result was achieved by 
comparing the data for recovery after hyperoxia with baseline and similarly for hypercapnia; 
both diameter and flow values were significantly lower following hyperoxia compared to the 
preceding baseline, irrespective of gas provocation paradigm. The persistent 
vasoconstriction after hyperoxia may be explained by an effect of tissue oxygenation and the 
half-life of endothelin-1. It is known that NO has a half-life of approximately 5 seconds or 
less 127 but the biological half life of endothelin-1 is 1.4 to 3.6 minutes, while other studies 
suggest a half-life of 35 minutes 128. In addition, the persistent vasoconstriction following 
pronounced hyperoxia (i.e. approximately 94% inspired O2) could even reflect oxidative 
damage effects at the level of the retinal vasculature 129. A limitation of our study is that the 
transition from one condition to the next in terms of arterial gas concentration is not square 
wave; however, the slope of the arterial gas concentration transition is expected to be 
equivalent across conditions (i.e. hyperoxia and hypercapnia) thereby still suggesting the 
presence of a persistent vasoconstrictive order effect. 
 
The COR of retinal blood flow was greater for arteriolar measurement sites with wider 
baseline diameters than those with narrower baseline diameters; however, the ratio of group 
mean COR to group mean blood flow (6.55 versus 7.58 for narrow and wide diameter sites, 
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respectively) was similar across the measurement sites. These data demonstrate that the 
repeatability of retinal blood flow measurements in absolute terms is lower for smaller 
diameter vessels but when related to the group mean flow there is little, if any, difference in 
repeatability between smaller and larger diameter vessels. These findings need to take into 
account the range of vessel diameters that were investigated in this study i.e. group mean 
diameter 92.40 µm (SD 13.64) versus 116.68 µm (SD 12.68) diameter.  
 
Finally, the pilot study data (i.e. Chapter 4) suggested that there is no effect of aging on the 
relationship between the magnitude of retinal vascular reactivity and vessel diameter. We 
might not have observed any influence of age on the relationship between retinal vascular 
reactivity and vessel diameter due to some limitations. These limitations could include the 
small sample size, the relatively small difference in ages between two groups, subject 
fatigue which limited the protocol design for the older age group and, finally, the gas 
provocations utilized may overwhelm any vascular reactivity deficit associated with healthy 
aging. The difference between the results of this study and previous work may also be 
explained by the differences in the technique used to assess hemodynamic and to provoke 
vascular reactivity. Similar provocations have been shown to be sensitive to effects of 
diabetes mellitus 132 on retinal vascular reactivity. Future work will investigate the effect of 
healthy aging on stepped increments of gas stimuli on retinal hemodynamics. 
 
In summary, this work demonstrated that the magnitude of retinal vascular reactivity was 
greater for arteriolar measurement sites with wider baseline diameter. In addition, it 
demonstrated that the percent magnitude of vascular reactivity was not influenced by 
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baseline arteriolar measurement site diameter, although the variability of response was 
greater for the wider measurement sites. It was also demonstrated that hyperoxic 
provocation resulted in a persistent vasoconstriction up to 10 minutes after cessation of the 
stimulus. Furthermore, the study demonstrated that the repeatability of retinal blood flow 
measurements in absolute terms is lower for smaller diameter vessels. Finally, the pilot 
study demonstrated that there is no effect of healthy aging on the relationship between the 






 1.  Dorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE et al. Nitric oxide 
regulates retinal vascular tone in humans. Am.J.Physiol Heart Circ.Physiol 
2003;285:H631-H636. 
 2.  Dorner GT, Garhofer G, Huemer KH, Riva CE, Wolzt M, Schmetterer L. 
Hyperglycemia affects flicker-induced vasodilation in the retina of healthy subjects. 
Vision Res. 2003;43:1495-500. 
 3.  Polak K, Schmetterer L, Riva CE. Influence of flicker frequency on flicker-induced 
changes of retinal vessel diameter. Invest Ophthalmol.Vis.Sci. 2002;43:2721-6. 
 4.  Michelson G, Patzelt A, Harazny J. Flickering light increases retinal blood flow. 
Retina 2002;22:336-43. 
 5.  Buerk DG, Riva CE, Cranstoun SD. Nitric oxide has a vasodilatory role in cat optic 
nerve head during flicker stimuli. Microvasc.Res. 1996;52:13-26. 
 6.  Falsini B, Riva CE, Logean E. Flicker-evoked changes in human optic nerve blood 




 7.  Riva CE, Falsini B, Logean E. Flicker-evoked responses of human optic nerve head 
blood flow: luminance versus chromatic modulation. Invest Ophthalmol.Vis.Sci. 
2001;42:756-62. 
 8.  Formaz F, Riva CE, Geiser M. Diffuse luminance flicker increases retinal vessel 
diameter in humans. Curr.Eye Res. 1997;16:1252-7. 
 9.  Johnson PC. Autoregulation of blood flow. Circ.Res. 1986;59:483-95. 
 10.  Dorner GT, Garhofer G, Zawinka C, Kiss B, Schmetterer L. Response of retinal 
blood flow to CO2-breathing in humans. Eur.J.Ophthalmol. 2002;12:459-66. 
 11.  Kety SS, Schmidt CF. The effects of altered  arterial tensions of carbon dioxide and 
oxygen on cerebral blood flow and cerebral oxygen consumption of normal young 
men. J Clin.Invest 1948;27:484-92. 
 12.  Kaufman PL, Alm A. Adler's Physiology of the Eye. 10th Edition ed. St. Louis: 
Mosby, 2003. 
 13.  Haefliger IO, Flammer J, Beny JL, Luscher TF. Endothelium-dependent vasoactive 
modulation in the ophthalmic circulation. Prog.Retin.Eye Res. 2001;20:209-25. 
 14.  Levick J.R. An Introduction to Cardiovascular Physiology. 4th Edition ed. London: 
Amember of the Hodder Headline Group, 2003. 
 15.  Remington LA. Clinical Anatomy of the Visual System. 2nd Edition ed. St. Louis, 
Missouri: Elsevier, 2005. 
 
 114
 16.  Harris A, Jonescu-Cuypers CP, Kagemann L, Ciulla TA, Krieglstein G. Atlas of 
Ocular Blood Flow: Vasculr Anatomy, Pathophysiology, and Metabolism. 
Philadelphia; Elsevier. 2003. 
 17.  Saint-Geniez M, D'Amore PA. Development and pathology of the hyaloid, choroidal 
and retinal vasculature. Int.J.Dev.Biol. 2004;48:1045-58. 
 18.  Levick JR. Cardivascular Physiology. London: Arnold, 2000: 15-28. 
 19.  Guyton A.C., Hall J. Textbook of Medical Physiology. 10th edition ed. Philadelphia, 
Penncylvania: W.B. Saunders Company, 2000: 144-50. 
 20.  Feke GT, Tagawa H, Deupree DM, Goger DG, Sebag J, Weiter JJ. Blood flow in the 
normal human retina. Invest Ophthalmol.Vis.Sci. 1989;30:58-65. 
 21.  Riva CE, Grunwald JE, Sinclair SH, Petrig BL. Blood velocity and volumetric flow 
rate in human retinal vessels. Invest Ophthalmol.Vis.Sci. 1985;26:1124-32. 
 22.  Pournaras Constantin J. In: Kaiser H.J. FJHPh, ed. Ocular Blood Flow New Insights 
into the Pathogenesis of Ocular Diseases. Basel, Switzerland: S. Karger AG, 1996: 
40-50. 
 23.  Harris A, Kagemann L, Cioffi GA. Assessment of human ocular hemodynamics. 
Surv.Ophthalmol. 1998;42:509-33. 
 24.  Dosne AM, Dupuy E, Bodevin E. Production of a fibrinolytic inhibitor by cultured 
endothelial cells derived from human umbilical vein. Thromb.Res. 1978;12:377-87. 
 
 115
 25.  Orgul S, Gugleta K, Flammer J. Physiology of perfusion as it relates to the optic 
nerve head. Surv.Ophthalmol. 1999;43 Suppl 1:S17-S26. 
 26.  Johnson PC. Review of previous studies and current theories of autoregulation. 
Circ.Res. 1964;15:SUPPL-9. 
 27.  Harris A, Ciulla TA, Chung HS, Martin B. Regulation of retinal and optic nerve 
blood flow. Arch.Ophthalmol. 1998;116:1491-5. 
 28.  Busse R, Luckhoff A, Bassenge E. Endothelium-derived relaxant factor inhibits 
platelet activation. Naunyn Schmiedebergs Arch.Pharmacol. 1987;336:566-71. 
 29.  Ignarro L.J., Byrns R.E, Wood K.S. Pharmacological and biochemical properties of 
endothelium-derived relaxing factor (EDRF): evidence that it is closely related to 
nitric oxide (NO) radical. Circulation 74 Suppl II, 1986;p. S287. 
 30.  Moncada S, Palmer RM, Gryglewski RJ. Mechanism of action of some inhibitors of 
endothelium-derived relaxing factor. Proc.Natl.Acad.Sci.U.S.A 1986;83:9164-8. 
 31.  Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological 
activity of endothelium-derived relaxing factor. Nature 1987;327:524-6. 
 32.  Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular 
endothelium: interactions between prostacyclin and nitric oxide. Br.J.Pharmacol. 
1987;92:639-46. 
 33.  Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human 
platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8. 
 
 116
 34.  Baynes J and Dominiczak. In: Medical Biochemistry. London: Mosby, 1999: 469-85. 
 35.  Schmetterer L, Polak K. Role of nitric oxide in the control of ocular blood flow. 
Prog.Retin.Eye Res. 2001;20:823-47. 
 36.  Venkataraman ST, Hudson C, Fisher JA, Flanagan JG. The impact of hypercapnia on 
retinal capillary blood flow assessed by scanning laser Doppler flowmetry. 
Microvasc.Res. 2005;69:149-55. 
 37.  Schiffrin EL, Touyz RM. Vascular biology of endothelin. J Cardiovasc.Pharmacol. 
1998;32 Suppl 3:S2-13. 
 38.  Mamluk R, Levy N, Rueda B, Davis JS, Meidan R. Characterization and regulation 
of type A endothelin receptor gene expression in bovine luteal cell types. 
Endocrinology 1999;140:2110-6. 
 39.  Novotny H.R., Alvis D.L. A method of photographing fluorescence in circulating 
blood in the human retina. Circulation 1961;24:82-6. 
 40.  Preussner PR, Richard G, Darrelmann O, Weber J, Kreissig I. Quantitative 
measurement of retinal blood flow in human beings by application of digital image-
processing methods to television fluorescein angiograms. Graefes 
Arch.Clin.Exp.Ophthalmol. 1983;221:110-2. 
 41.  Wolf S, Jung F, Kiesewetter H, Korber N, Reim M. Video fluorescein angiography: 




 42.  Kiss B, Polska E, Dorner G, Polak K, Findl O, Mayrl GF et al. Retinal blood flow 
during hyperoxia in humans revisited: concerted results using different measurement 
techniques. Microvasc.Res. 2002;64:75-85. 
 43.  Dallinger S, Dorner GT, Wenzel R, Graselli U, Findl O, Eichler HG et al. 
Endothelin-1 contributes to hyperoxia-induced vasoconstriction in the human retina. 
Invest Ophthalmol.Vis.Sci. 2000;41:864-9. 
 44.  De Mey JG, Vanhoutte PM. Anoxia and endothelium-dependent reactivity of the 
canine femoral artery. J.Physiol 1983;335:65-74. 
 45.  Kim P, Sundt TM, Jr., Vanhoutte PM. Alterations in endothelium-dependent 
responsiveness of the canine basilar artery subarachnoid hemorrhage. J.Neurosurg. 
1988;69:239-46. 
 46.  Lüscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. 
CRC Press, Boca Raton, FL 1990;1-228. 
 47.  Vanhoutte PM, Rubanyi GM, Miller VM, Houston DS. Modulation of vascular 
smooth muscle contraction by the endothelium. Annu.Rev.Physiol 1986;48:307-20. 
 48.  D'Amore P, Black CM, Garcia JGN, Haudenschild C, Hechtman HB, Jain RK et al. 
Microvascular Research. 2006. 
 49.  Harder DR. Pressure-induced myogenic activation of cat cerebral arteries is 
dependent on intact endothelium. Circ.Res. 1987;60:102-7. 
 
 118
 50.  Harder DR, Kauser K, Roman RJ, Lombard JH. Mechanisms of pressure-induced 
myogenic activation of cerebral and renal arteries: role of the endothelium. 
J.Hypertens.Suppl 1989;7:S11-S15. 
 51.  Davies PF, Tripathi SC. Mechanical stress mechanisms and the cell. An endothelial 
paradigm. Circ.Res. 1993;72:239-45. 
 52.  Levick JR. Cardiac cycle. Cardiovascular physiology. London; Arnold. 2000: 107. 
 53.  Strenn K, Menapace R, Rainer G, Findl O, Wolzt M, Schmetterer L. Reproducibility 
and sensitivity of scanning laser Doppler flowmetry during graded changes in PO2. 
Br.J.Ophthalmol. 1997;81:360-4. 
 54.  Riva CE, Grunwald JE, Sinclair SH. Laser Doppler Velocimetry study of the effect 
of pure oxygen breathing on retinal blood flow. Invest Ophthalmol.Vis.Sci. 
1983;24:47-51. 
 55.  Fallon TJ, Maxwell D, Kohner EM. Retinal vascular autoregulation in conditions of 
hyperoxia and hypoxia using the blue field entoptic phenomenon. Ophthalmology 
1985;92:701-5. 
 56.  Eperon G, Johnson M, David NJ. The effect of arterial PO2 on relative retinal blood 
flow in monkeys. Invest Ophthalmol. 1975;14:342-52. 
 57.  Riva CE, Pournaras CJ, Tsacopoulos M. Regulation of local oxygen tension and 
blood flow in the inner retina during hyperoxia. J.Appl.Physiol 1986;61:592-8. 
 
 119
 58.  Takagi C, King GL, Takagi H, Lin YW, Clermont AC, Bursell SE. Endothelin-1 
action via endothelin receptors is a primary mechanism modulating retinal 
circulatory response to hyperoxia. Invest Ophthalmol.Vis.Sci. 1996;37:2099-109. 
 59.  Schmetterer L, Wolzt M, Lexer F, Alschinger C, Gouya G, Zanaschka G et al. The 
effect of hyperoxia and hypercapnia on fundus pulsations in the macular and optic 
disc region in healthy young men. Exp.Eye Res. 1995;61:685-90. 
 60.  Langhans M, Michelson G, Groh MJ. Effect of breathing 100% oxygen on retinal 
and optic nerve head capillary blood flow in smokers and non-smokers. 
Br.J.Ophthalmol. 1997;81:365-9. 
 61.  Nagel E, Vilser W, Lanzl I. Age, blood pressure, and vessel diameter as factors 
influencing the arterial retinal flicker response. Invest Ophthalmol.Vis.Sci. 
2004;45:1486-92. 
 62.  Knudtson MD, Klein BE, Klein R, Wong TY, Hubbard LD, Lee KE et al. Variation 
associated with measurement of retinal vessel diameters at different points in the 
pulse cycle. Br.J.Ophthalmol. 2004;88:57-61. 
 63.  Jeppesen P, Gregersen PA, Bek T. The age-dependent decrease in the myogenic 
response of retinal arterioles as studied with the Retinal Vessel Analyzer. Graefes 
Arch.Clin.Exp.Ophthalmol. 2004;242:914-9. 
 64.  Boehm AG, Koeller AU, Pillunat LE. The effect of age on optic nerve head blood 
flow. Invest Ophthalmol.Vis.Sci. 2005;46:1291-5. 
 
 120
 65.  Groh MJ, Michelson G, Langhans MJ, Harazny J. Influence of age on retinal and 
optic nerve head blood circulation. Ophthalmology 1996;103:529-34. 
 66.  Harris A, Harris M, Biller J, Garzozi H, Zarfty D, Ciulla TA et al. Aging affects the 
retrobulbar circulation differently in women and men. Arch.Ophthalmol. 
2000;118:1076-80. 
 67.  Grunwald JE, Hariprasad SM, DuPont J. Effect of aging on foveolar choroidal 
circulation. Arch.Ophthalmol. 1998;116:150-4. 
 68.  Blum M, Bachmann K, Strobel J. [Age-correlation of blood pressure induced 
myogenic autoregulation of human retinal arterioles in 40 volunteers]. 
Klin.Monatsbl.Augenheilkd. 2000;217:225-30. 
 69.  Bursell SE, Clermont AC, Shiba T, King GL. Evaluating retinal circulation using 
video fluorescein angiography in control and diabetic rats. Curr.Eye Res. 
1992;11:287-95. 
 70.  Wolf S, Arend O, Toonen H, Bertram B, Jung F, Reim M. Retinal capillary blood 
flow measurement with a scanning laser ophthalmoscope. Preliminary results. 
Ophthalmology 1991;98:996-1000. 
 71.  Miyamoto K, Ogura Y, Nishiwaki H, Matsuda N, Honda Y, Kato S et al. Evaluation 
of retinal microcirculatory alterations in the Goto-Kakizaki rat. A spontaneous model 
of non-insulin-dependent diabetes. Invest Ophthalmol.Vis.Sci. 1996;37:898-905. 
 
 121
 72.  Lee ET, Rehkopf PG, Warnicki JW, Friberg T, Finegold DN, Cape EG. A new 
method for assessment of changes in retinal blood flow. Med.Eng Phys. 
1997;19:125-30. 
 73.  Schmetterer L, Wolzt M. Ocular blood flow and associated functional deviations in 
diabetic retinopathy. Diabetologia 1999;42:387-405. 
 74.  Nakahashi K, Asai T, Okubo K, Yamamoto M, Masumi K. [Analysis of the retinal 
blood flow by means of the blue field entoptic phenomenon and simulation of 
entoptic leucocytes with a personal-computer system]. Nippon Ganka Gakkai Zasshi 
1989;93:533-9. 
 75.  Kolodjaschna J, Berisha F, Lung S, Schaller G, Polska E, Jilma B et al. LPS-induced 
microvascular leukocytosis can be assessed by blue-field entoptic phenomenon. 
Am.J.Physiol Heart Circ.Physiol 2004;287:H691-H694. 
 76.  Harris A, Kagemann L, Cioffi GA. Assessment of human ocular hemodynamics. 
Surv.Ophthalmol. 1998;42:509-33. 
 77.  Harris A, Chung HS, Ciulla TA, Kagemann L. Progress in measurement of ocular 
blood flow and relevance to our understanding of glaucoma and age-related macular 
degeneration. Prog.Retin.Eye Res. 1999;18:669-87. 
 78.  Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H. Noncontact, two-dimensional 




 79.  Tamaki Y, Araie M, Tomita K, Nagahara M, Tomidokoro A, Fujii H. Real-time 
measurement of human optic nerve head and choroid circulation, using the laser 
speckle phenomenon. Jpn.J Ophthalmol. 1997;41:49-54. 
 80.  Briers JD, Fercher AF. Retinal blood-flow visualization by means of laser speckle 
photography. Invest Ophthalmol.Vis.Sci. 1982;22:255-9. 
 81.  Harris A, et.al. Atlas of Ocular Blood Flow. Philadelphia, Pennsylvania: Butterworth 
Heinemann, 2003. 
 82.  Schmetterer L, Dallinger S, Findl O, Strenn K, Graselli U, Eichler HG et al. 
Noninvasive investigations of the normal ocular circulation in humans. Invest 
Ophthalmol.Vis.Sci. 1998;39:1210-20. 
 83.  Boehm AG, Pillunat LE, Koeller U, Katz B, Schicketanz C, Klemm M et al. 
Regional distribution of optic nerve head blood flow. Graefes 
Arch.Clin.Exp.Ophthalmol. 1999;237:484-8. 
 84.  Bebie H. In: Kaiser H.J. FJHPh, ed. Ocular Blood Flow. Basel: S. Karger AG, 1996: 
93-9. 
 85.  Riva CE, Grunwald JE, Sinclair SH, Okeefe K. Fundus Camera Based Retinal Ldv. 
Applied Optics 1981;20:117-20. 
 86.  Riva CE, Feke GT, Eberli B, Benary V. Bidirectional Ldv System for Absolute 
Measurement of Blood Speed in Retinal-Vessels. Applied Optics 1979;18:2301-6. 
 
 123
 87.  Feke GT, Riva CE. Laser Doppler measurements of blood velocity in human retinal 
vessels. J Opt Soc.Am. 1978;68:526-31. 
 88.  Riva CE, Feke GT, Ben Sira I. Fluorescein dye-dilution technique and retinal 
circulation. Am.J Physiol 1978;234:H315-H322. 
 89.  Harris A, Kagemann L, Cioffi GA. Assessment of human ocular hemodynamics. 
Surv.Ophthalmol. 1998;42:509-33. 
 90.  Riva CE, Grunwald JE, Sinclair SH, Petrig BL. Blood velocity and volumetric flow 
rate in human retinal vessels. Invest Ophthalmol.Vis.Sci. 1985;26:1124-32. 
 91.  Gilmore ED, Hudson C, Preiss D, Fisher J. Retinal arteriolar diameter, blood 
velocity and blood flow response to an isocapnic hyperoxic provocation. 
Am.J.Physiol Heart Circ.Physiol 2005. 
 92.  Guan K, Hudson C, Flanagan JG. Variability and repeatability of retinal blood flow 
measurements using the Canon Laser Blood Flowmeter. Microvasc.Res. 
2003;65:145-51. 
 93.  Riva CE, Logean E, Falsini B. Visually evoked hemodynamical response and 
assessment of neurovascular coupling in the optic nerve and retina. Prog.Retin.Eye 
Res. 2005;24:183-215. 
 94.  Michelson G, Schmauss B. Two dimensional mapping of the perfusion of the retina 
and optic nerve head. Br.J.Ophthalmol. 1995;79:1126-32. 
 
 124
 95.  Feke GT, Yoshida A, Schicketanz C. Laser based instruments for ocular blood flow 
assessment. J Biomed Opt 3 1998;415-22. 
 96.  Delori FC, Fitch KA, Feke GT, Deupree DM, Weiter JJ. Evaluation of micrometric 
and microdensitometric methods for measuring the width of retinal vessel images on 
fundus photographs. Graefes Arch.Clin.Exp.Ophthalmol. 1988;226:393-9. 
 97.  Milbocker MT, Feke GT, Goger DG. Laser Doppler velocimetry stabilized in one 
dimension. IEEE Trans.Biomed.Eng 1991;38:928-30. 
 98.  Yoshida A, Feke GT, Mori F, Nagaoka T, Fujio N, Ogasawara H et al. 
Reproducibility and clinical application of a newly developed stabilized retinal laser 
Doppler instrument. Am.J Ophthalmol. 2003;135:356-61. 
 99.  Riva CE et al. Laser Doppler velocimetry and blue field stimulation technique. In: 
Masters BR, ed. Noninvasive Diagnostic Techniques in Ophthalmology. New york; 
Springer. 1990: 390-409. 
 100.  Dumskyj MJ, Aldington SJ, Dore CJ, Kohner EM. The accurate assessment of 
changes in retinal vessel diameter using multiple frame electrocardiograph 
synchronised fundus photography. Curr.Eye Res. 1996;15:625-32. 
 101.  Michelson G, Schmauss B, Langhans MJ, Harazny J, Groh MJ. Principle, validity, 
and reliability of scanning laser Doppler flowmetry. J.Glaucoma. 1996;5:99-105. 
 
 125
 102.  Butt Z, McKillop G, O'Brien C, Allan P, Aspinall P. Measurement of ocular blood 
flow velocity using colour Doppler imaging in low tension glaucoma. Eye 1995;9 ( 
Pt 1):29-33. 
 103.  Gilmore ED, Hudson C, Venkataraman ST, Preiss D, Fisher J. Comparison of 
different hyperoxic paradigms to induce vasoconstriction: implications for the 
investigation of retinal vascular reactivity. Invest Ophthalmol.Vis.Sci. 2004;45:3207-
12. 
 104.  Sommer LZ, Iscoe S, Robicsek A, Kruger J, Silverman J, Rucker J et al. A simple 
breathing circuit minimizing changes in alveolar ventilation during hyperpnoea. 
Eur.Respir.J 1998;12:698-701. 
 105.  Gilmore ED, Hudson C, Preiss D, Fisher J. Retinal arteriolar diameter, blood 
velocity, and blood flow response to an isocapnic hyperoxic provocation. Am.J 
Physiol Heart Circ.Physiol 2005;288:H2912-H2917. 
 106.  Venkataraman ST, Hudson C, Fisher JA, Flanagan JG. Novel methodology to 
comprehensively assess retinal arteriolar vascular reactivity to hypercapnia. 
Microvasc.Res. 2006. 
 107.  Giller CA, Bowman G, Dyer H, Mootz L, Krippner W. Cerebral arterial diameters 




 108.  MacKenzie ET, Strandgaard S, Graham DI, Jones JV, Harper AM, Farrar JK. Effects 
of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood 
flow, and the blood-brain barrier. Circ.Res. 1976;39:33-41. 
 109.  Chilian WM, Layne SM. Coronary microvascular responses to reductions in 
perfusion pressure. Evidence for persistent arteriolar vasomotor tone during coronary 
hypoperfusion. Circ.Res. 1990;66:1227-38. 
 110.  Chung HS, Harris A, Halter PJ, Kagemann L, Roff EJ, Garzozi HJ et al. Regional 
differences in retinal vascular reactivity. Invest Ophthalmol.Vis.Sci. 1999;40:2448-
53. 
 111.  Grunwald JE, Riva CE, Petrig BL, Sinclair SH, Brucker AJ. Effect of pure O2-
breathing on retinal blood flow in normals and in patients with background diabetic 
retinopathy. Curr.Eye Res. 1984;3:239-41. 
 112.  Harris A, Arend O, Kopecky K, Caldemeyer K, Wolf S, Sponsel W et al. 
Physiological perturbation of ocular and cerebral blood flow as measured by 
scanning laser ophthalmoscopy and color Doppler imaging. Surv.Ophthalmol. 
1994;38 Suppl:S81-S86. 
 113.  Hickam J.B., Sieker H.O., Frayser R. Studies of retinal circulation and A-V oxygen 
difference in man. Trans.Am.Clin.Climatol.Assoc. 1959;71:34-44. 
 114.  Luksch A, Garhofer G, Imhof A, Polak K, Polska E, Dorner GT et al. Effect of 




 115.  Pakola SJ, Grunwald JE. Effects of oxygen and carbon dioxide on human retinal 
circulation. Invest Ophthalmol.Vis.Sci. 1993;34:2866-70. 
 116.  Polska E, Kircher K, Ehrlich P, Vecsei PV, Schmetterer L. RI in central retinal artery 
as assessed by CDI does not correspond to retinal vascular resistance. Am.J Physiol 
Heart Circ.Physiol 2001;280:H1442-H1447. 
 117.  Rassam SM, Patel V, Chen HC, Kohner EM. Regional retinal blood flow and 
vascular autoregulation. Eye 1996;10 ( Pt 3):331-7. 
 118.  Roff EJ, Harris A, Chung HS, Hosking SL, Morrison AM, Halter PJ et al. 
Comprehensive assessment of retinal, choroidal and retrobulbar haemodynamics 
during blood gas perturbation. Graefes Arch.Clin.Exp.Ophthalmol. 1999;237:984-90. 
 119.  Sponsel WE, DePaul KL, Zetlan SR. Retinal hemodynamic effects of carbon 
dioxide, hyperoxia, and mild hypoxia. Invest Ophthalmol.Vis.Sci. 1992;33:1864-9. 
 120.  Haefliger IO, Lietz A, Griesser SM, Ulrich A, Schotzau A, Hendrickson P et al. 
Modulation of Heidelberg Retinal Flowmeter parameter flow at the papilla of healthy 
subjects: effect of carbogen, oxygen, high intraocular pressure, and beta-blockers. 
Surv.Ophthalmol. 1999;43 Suppl 1:S59-S65. 
 121.  Harris A, Arend O, Wolf S, Cantor LB, Martin BJ. CO2 dependence of retinal 
arterial and capillary blood velocity. Acta Ophthalmol.Scand. 1995;73:421-4. 
 122.  Dorner GT, Garhoefer G, Zawinka C, Kiss B, Schmetterer L. Response of retinal 
blood flow to CO2-breathing in humans. Eur.J.Ophthalmol. 2002;12:459-66. 
 
 128
 123.  Kida T, Harino S, Sugiyama T, Kitanishi K, Iwahashi Y, Ikeda T. Change in retinal 
arterial blood flow in the contralateral eye of retinal vein occlusion during glucose 
tolerance test. Graefes Arch.Clin.Exp.Ophthalmol. 2002;240:342-7. 
 124.  Lamport H., Baez S. Physical properties of small arterial vessels. Physiol Rev.Suppl 
1962;5:328-52. 
 125.  Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, Patterson JL, Jr. 
Responses of cerebral arteries and arterioles to acute hypotension and hypertension. 
Am.J Physiol 1978;234:H371-H383. 
 126.   In: Shepro D, D'Amore P, Black C.M, Garcia JGN, Granger DN, Haudenschild C et 
al, eds. Elsevier Academic Press, 2006: 401. 
 127.  Hakim TS, Sugimori K, Camporesi EM, Anderson G. Half-life of nitric oxide in 
aqueous solutions with and without haemoglobin. Physiol Meas. 1996;17:267-77. 
 128.  Parker JD, Thiessen JJ, Reilly R, Tong JH, Stewart DJ, Pandey AS. Human 
endothelin-1 clearance kinetics revealed by a radiotracer technique. J 
Pharmacol.Exp.Ther. 1999;289:261-5. 
 129.  Iscoe S, Fisher JA. Hyperoxia-induced hypocapnia: an underappreciated risk. Chest 
2005;128:430-3. 
 130.  Meadows GE, Dunroy HM, Morrell MJ, Corfield DR. Hypercapnic cerebral vascular 




 131.  Vucetic M, Jensen PK, Jansen EC. Diameter variations of retinal blood vessels 
during and after treatment with hyperbaric oxygen. Br.J Ophthalmol. 2004;88:771-5. 
 132.  Gilmore, E. D. Doctoral thesis.  2006.  University of Waterloo.  
Ref Type: Thesis/Dissertation 
 133.  Wahren J, Saltin B, Jorfeldt L, Pernow B. Influence of age on the local circulatory 
adaptation to leg exercise. Scand.J Clin.Lab Invest 1974;33:79-86. 
 134.  Proctor DN, Shen PH, Dietz NM, Eickhoff TJ, Lawler LA, Ebersold EJ et al. 
Reduced leg blood flow during dynamic exercise in older endurance-trained men. J 
Appl.Physiol 1998;85:68-75. 
 135.  Grunwald JE, Piltz J, Patel N, Bose S, Riva CE. Effect of aging on retinal macular 
microcirculation: a blue field simulation study. Invest Ophthalmol.Vis.Sci. 
1993;34:3609-13. 
 136.  Muller-Delp JM. Aging-induced adaptations of microvascular reactivity. 
Microcirculation. 2006;13:301-14. 
 137.  Barton M, Cosentino F, Brandes RP, Moreau P, Shaw S, Luscher TF. Anatomic 
heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension 
1997;30:817-24. 
 138.  Delp MD, Brown M, Laughlin MH, Hasser EM. Rat aortic vasoreactivity is altered 
by old age and hindlimb unloading. J Appl.Physiol 1995;78:2079-86. 
 
 130
 139.  Docherty JR. Cardiovascular responses in ageing: a review. Pharmacol.Rev. 
1990;42:103-25. 
 140.  Kahonen M, Karjala K, Hutri-Kahonen N, Wu X, Jaatinen P, Riihioja P et al. 
Influence of chronic ethanol consumption on arterial tone in young and aged rats. 
Am.J Physiol 1999;276:H464-H471. 
 141.  Koga T, Takata Y, Kobayashi K, Takishita S, Yamashita Y, Fujishima M. Ageing 
suppresses endothelium-dependent relaxation and generates contraction mediated by 
the muscarinic receptors in vascular smooth muscle of normotensive Wistar-Kyoto 
and spontaneously hypertensive rats. J Hypertens.Suppl 1988;6:S243-S245. 
 142.  Marin J, Rodriguez-Martinez MA. Age-related changes in vascular responses. 
Exp.Gerontol. 1999;34:503-12. 
 143.  Hansson L, Berglund G, Andersson O, Holm M. Controlled trial of acebutolol in 
hypertension. Eur.J Clin.Pharmacol. 1977;12:89-92. 
 144.  Dohi Y, Luscher TF. Aging differentially affects direct and indirect actions of 
endothelin-1 in perfused mesenteric arteries of the rat. Br.J Pharmacol. 
1990;100:889-93. 
 145.  Moreau P, d'Uscio LV, Luscher TF. Structure and reactivity of small arteries in 
aging. Cardiovasc.Res. 1998;37:247-53. 
 146.  Weinheimer G, Dooley DJ, Cazzonelli M, Osswald H. Aging and endothelin-1 
induced vascular contractions. Experientia 1990;46:1008-9. 
 
 131
 147.  Donato AJ, Lesniewski LA, Delp MD. The effects of aging and exercise training on 
endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles. 
Cardiovasc.Res. 2005;66:393-401. 
 148.  Ishihata A, Katano Y, Nakamura M, Doi K, Tasaki K, Ono A. Differential 
modulation of nitric oxide and prostacyclin release in senescent rat heart stimulated 
by angiotensin II. Eur.J Pharmacol. 1999;382:19-26. 
 149.  Korzick DH, Muller-Delp JM, Dougherty P, Heaps CL, Bowles DK, Krick KK. 
Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: role of protein 
kinase C. Cardiovasc.Res. 2005;66:384-92. 
 150.  Muller-Delp J, Spier SA, Ramsey MW, Lesniewski LA, Papadopoulos A, Humphrey 
JD et al. Effects of aging on vasoconstrictor and mechanical properties of rat skeletal 
muscle arterioles. Am.J Physiol Heart Circ.Physiol 2002;282:H1843-H1854. 
 151.  Shipley RD, Muller-Delp JM. Aging decreases vasoconstrictor responses of coronary 
resistance arterioles through endothelium-dependent mechanisms. Cardiovasc.Res. 
2005;66:374-83. 
 152.  Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs 
endothelium-dependent vasodilation in forearm resistance vessels of humans. 
Hypertension 1996;27:849-53. 
 153.  Tschudi MR, Luscher TF. Age and hypertension differently affect coronary 
contractions to endothelin-1, serotonin, and angiotensins. Circulation 1995;91:2415-
22.  
